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Pregnant women are vulnerable due to the pregnancy-induced suppressed immunity in 
malaria-endemic areas. Asymptomatic malaria in pregnancy (MiP) threatens both the 
mother, fetus, and neonate via chronic placental malaria which impacts maternal-neonatal 
exchange. Some studies reported that MiP risk factors vary across locations, however, 
there are few studies on MiP and pregnancy outcome in Nigeria. The purpose of this 
study was to investigate the association between asymptomatic placental malaria 
infection and pregnancy outcome among parturients in Asaba, Delta State, Nigeria. This 
study was developed with a quantitative methodology that utilized primary and secondary 
healthcare data from 483 subjects aged 18–49 years from four healthcare facilities 
between May and July 2021. The Socio-Ecological Model framework was used to 
explain how parturients can achieve improved pregnancy outcome via the mobilization of 
multi-levels supports to enhance the compliance of parturients to malaria interventions. 
Three research questions with three sets of hypotheses were tested with the binomial 
logistic regression and Chi-square tests. The findings showed a statistically significant 
association between placental malaria parasitemia by microscopy, intermittent preventive 
treatment in pregnancy with sulfadoxine-pyrimethamine, use of complementary and 
alternative medicine, and pregnancy outcome in the study population. The findings of this 
study could inform malaria control policymaking in Asaba and Delta State on tracking 
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Chapter 1: Introduction to the Study 
Malaria accounts for the highest mortality compared to all other infectious 
diseases pooled at the global and sub-Saharan Africa (SSA) regional levels. The greatest 
burden of this vector-borne disease is in the SSA, with Nigeria bearing a 25% burden and 
ranking highest/first in central Africa bearing 50% of the global burden (Center for 
Disease Control and Prevention [CDC], 2020; World Health Organization [WHO], 
2020).  
There is documented evidence in the current literature of the negative impact of 
malaria pregnancy (MiP). MiP is a public health concern that is impacting huge economic 
and human resources at various levels of society (WHO, 2020). The United Nation 
International Children’s Emergency Fund (UNICEF) stated that malaria is an urgent 
public health concern, and all stakeholders should concentrate efforts for the elimination 
(reduction of the incidence rate of a disease to zero levels in a defined geographical 
location via thoughtful interventions) and eradication (permanent reduction of the 
incidence of a particular disease to zero levels at global level via calculated efforts and 
subsequent interventions are not required) of the disease globally (UNICEF, 2020; WHO, 
2016).  
 Onyemaechi and Malann (2020) reported that parturients are a high-risk group for 
malaria due to their suppressed immunity by pregnancy. The disease burden of malaria in 
Nigeria is enormous; among parturients, it accounts for 70% morbidity, 15% anemia, and 
5% to 14% prevalence of low birth weight (LBW). An estimated 3.2 million people are at 
risk of malaria infection. At the global level, several efforts to eradicate the disease failed 
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to produce the hoped outcome for decades. An estimated 125 million parturients are at 
risk of malaria infection globally. Researchers have stated that parturients are a reservoir 
of the Plasmodium species via asymptomatic and submicroscopic presentation with 
placental parasitemia (Onyemaechi & Malann, 2020).  
 In Nigeria, there is an estimated 3,000 death from malaria resulting in 40% of 
health expenditures, 50% hospital visits, and up to 50% of hospital admissions annually 
(Onyemaechi & Malann, 2020). The complications of malaria disease vary based on the 
level of immunity. In Nigeria, malaria accounts for 70% of morbidity and 11% of 
mortality among pregnant women and was the reason for 63% of hospital visits in 
Nigeria in 2018. Parturients are four times as likely to get malaria and two times as likely 
to die of malaria than their nonpregnant counterparts (Onyemaechi & Malann, 2020). The 
clinical signs of malaria include fever, chills, loss of consciousness, convulsion, 
breathlessness, anemia, jaundice, and vital organ dysfunction. (Onyemaechi & Malann, 
2020).   
 Multifaceted factors account for the high malaria burden in Nigeria. Data from the 
2015 Nigeria Malaria Indicator Survey (NMIS) and the 2018 Nigeria Demographic and 
Health Survey (NDHS) revealed that the country is not making noticeable progress in 
malaria elimination and eradication  (National Population Commission [NPC] Nigeria 
and ICF, 2019; National Malaria Elimination Program [NMEP], National Population 
Commission [NPopC], National Bureau of Statistics [NBS], and ICF International, 2016).  
This study may help support a policy design of an appropriately focused intervention that 
will yield the visible outcome of the anticipated positive social change on MiP prevention 
3 
 
and control strategies. The study outcome may result in the mobilization of a multilevel 
support system of the socioecological model (SEM) framework for parturients to improve 
pregnancy outcome via an informed understanding and enhanced utilization of the 
existing malaria interventions. The Parturients and their neonates could benefit from 
reduction in the loss of lives and an increased economic resource in the study location 
and beyond. There could be an increase in malaria interventions uptake via an increased 
knowledge of effective interventions with cultural acceptance. The findings from this 
study may result in a reduction in the prevalence of MiP, and the morbidity and mortality 
associated with the infection via the knowledge from the study could result in better 
compliance to malaria interventions. There may be an improvement in the health, 
economic status, investment opportunity, and available income to parturients. Besides, 
the government may channel the vast resources spent on preventing and controlling 
malaria into enhancing community well-being.  
 The findings of this study may inform appropriate strategies for malaria 
interventions across all levels of society. It could also help the Asaba community in Delta 
State, Nigeria to recognize their specific risk factors and all the multilevel players 
(personal, relationship, community, and systems) that have interactions with pregnant 
women for an improved pregnancy outcome. 
The findings from this study could have social change impact via the 
strengthening of malaria control policy at the system levels, as well as at the personal 
(individual) and interpersonal (community) level of the SEM theoretical framework. The 
communication of study findings at the antenatal clinic (ANC) study sites (result 
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dissemination to subjects and stakeholders) and community town hall meeting could 
enhance social support from family and community members for parturients protection 
against mosquito bites and use of existing intervention for the disease control. Other 
possible positive social change includes the informed understanding and adoption of 
existing malaria interventions and improved economic resources derived from a malaria 
free community.  
 This chapter includes a summary of the selected topic, a preview of research 
related to the study topic, the background and appropriate literature about the theme of 
the study. Chapter 1 also includes the independent variables, dependent variables, and 
other variables for univariate analysis, research questions, and hypotheses. The chapter 
includes key definitions as well as the purpose of the study, the study’s significance, and 
the theoretical framework. A detailed discussion of the current literature was discussed in 
Chapter 2.  
Background of the Study 
 Malaria is a significant public health concern in Nigeria; 97% of Nigerians are at 
risk of this disease, with substantial morbidity and mortality statistics across various age 
groups (Yaya et al., 2018; WHO, 2020). Malaria impacts parturients and their neonate 
with complications and mortality. Malaria accounts for a substantial burden on health 
facilities, depletion of household income, low labor productivity, and national gross 
domestic product (GDP; WHO, 2019). The implications of asymptomatic malaria among 
parturients in deterring control efforts and maintaining the parasite cycle have widespread 
reports (Aguzie, 2018; Bardaji et al., 2017; Omer et al., 2017). Reports have associated 
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pregnant women with the parasite’s reservoir, delaying the extermination of the disease 
(Aguzie, 2018; Camona-Fonseca & Arango, 2017).  
  The failure to detect the parasite presence in peripheral and placenta blood 
through a rapid diagnostic test (RDT) and microscopy, combined with current drug 
failures due to rapid parasite mutation, necessitate improved research to address this 
concern, improved testing techniques with cost-efficient strategies are needed to achieve 
the testing before treatment mandate by the WHO (WHO, 2020). The absence of P.  
falciparum from peripheral circulation by the sequestration in the placenta further 
complicates treatment and resistance of MiP (Aguzie, 2018; Sungwa et al., 2017; WHO, 
2018). According to Sharma and Shukla (2017) the infected red blood cells (iRBCs) 
by P. falciparum causes inflammation, oxidative stress, and apoptosis to the placenta. 
The iRBCs cross the placenta to evade the host immune responses. These iRBCs darkens 
and thickens the placenta base impacting maternal and neonates exchange patterns, 
resulting in intrauterine growth retardation (IUGR), LBW, and other adverse pregnancy 
outcomes.  
 Agomo et al. (2016) recommended large scale studies to confirm the low level of 
mutation in the P. falciparum multidrug resistance (pfmdr) 1 gene on the efficacy of 
amodiaquine in preventing malaria in pregnancy. These authors reported the need for 
extensive studies in other locations/places to provide current data on predictors and risk 
factors for malaria in pregnancy to enable scale-up of malaria control efforts. According 
to WHO (2017) the benefit of malaria research among pregnant women is critical due to 
the observed drug failure and parasite resistance among them and their neonates. Malaria 
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infection is a preventable (based on existing interventions) cause of maternal and 
neonatal complications, morbidity, and mortality (WHO, 2017). The extensive reports on 
drug failure warrant further research in various locations to ascertain the mutant strain, 
mutation threshold (upper limit/level of mutation), and accelerate informed intervention 
approaches (Aguzie, 2018; WHO, 2019). 
 In this study, I accessed the placental malaria parasitemia by microscopy (PMPM) 
disease burden among asymptomatic pregnant women in the target population and its 
implication on maternal health (maternal anemia status) and neonatal health (baby’s birth 
weight and delivery term). The outcome of this research could improve the understanding 
of the prevalence of malaria infection among pregnant women and the association 
between asymptomatic malaria infection, intermittent preventive treatment in pregnancy 
with sulfadoxine-pyrimethamine (IPTp-SP) compliance, the use of complementary and 
alternative medicine (CAM), and pregnancy outcomes (maternal anemia, baby’s birth 
weight, and delivery term) in Asaba, Delta State, Nigeria. The use of CAM in this study 
refers to the use of herbal/plant/traditional medicine by parturients against malaria 
disease. 
 I reported the sensitivity of the testing techniques, and this study could contribute 
to the current understanding of the reasons the efforts of stakeholders for the elimination 
and eradication of malaria are not yielding the optimal results. This study quantified the 
disease burden in the target population and location. This population is vulnerable due to 
their lower immunity and residing in a high burden malaria location. There remains 
limited documentation for the intended area, population, and study location 
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(asymptomatic malaria infection and pregnancy outcome, pregnant women, Delta State, 
Nigeria). The results of the existing literature on malaria infection among pregnant 
women are heterogeneous, implying region/location specificity, thereby creating a gap 
for this study to determine the Asaba community specific and result-oriented 
interventions with adoption strategies, as well as prevailing risk factors of malaria 
infection. The study findings could determine the efficient interventions and tailored 
guidance against the risk factors in the study location.  
Problem Statement   
 The malaria problem in Nigeria is life-threatening as 97% of the people are at 
risk. There are various collaborations (individual, national, and international) to reduce 
the disease but have not yielded the expected result. Malaria is the second leading cause 
of death in Africa. The statistics of malaria disease morbidity and mortality are highest in 
Nigeria (Okeke, 2012). According to Gontie et al. (2020), malaria risk factors in 
pregnancy to both mother and fetus are enormous. The enumerated risk factors from 
previous studies on MiP include educational attainments, age, ANC visit, gestational age, 
parity (the total number of pregnancies beyond 20 weeks), gravidity (the total number of 
confirmed  pregnancies irrespective of the outcome), IPTp-SP compliance, and 
insecticide treated net (ITN) use (Gontie et al., 2020).  
 Asymptomatic malaria is deadly, especially among parturients, children, and 
visitors from nonmalarial areas. This is because it is often undetected, therefore not 
treated. After 8 to 30 days of infection, the condition begins with flu-like symptoms such 
as fever, headache, joints and muscular aches, vomiting, diarrhea, chills, and sweats. 
8 
 
Untreated malaria infection can result in brain damage and damage to other vital organs 
including the liver and kidneys. Pregnant women are among the most impacted by 
malaria because their previously acquired immunoglobulin (in endemic settings) is 
reduced during pregnancy (CDC, 2020). 
 Research indicates that malaria induced-anemia accounts for an estimated 10,000 
maternal death in Africa each year (WHO, 2020). The infection of the placental by P. 
falciparum impacts maternal and neonatal exchange patterns causing miscarriages, 
premature births, imparted fetal growth, development, and death (CDC, 2020).  
The WHO via the global technical group set a new goal on malaria eradication for 2030. 
The goal is aimed at reducing malaria by 90% via its elimination in 35 countries globally 
(WHO, 2016). The objective of this study was to examine the use of some malaria 
interventions (IPTp-SP and ITN) and to identify some risk factors (listed in current 
literature from studies in various locations) that relate to PMPM and pregnancy outcome 
in the study location.  
Purpose of the Study: The purpose of this study was to investigate the association 
between PMPM, IPTp-SP compliance, the use of CAM, and pregnancy outcome 
(maternal anemia, baby’s birth weight, and delivery term) among asymptomatic pregnant 
women presenting for delivery. I used quantitative methodology in a cross-sectional 
study design with deidentified survey questionnaires and secondary data collected from 
four healthcare facilities in Asaba, Delta State, southern Nigeria. The subject’s ITN 
ownership, ITN frequent use, ANC attendance, gravidae, age group, and educational 
attainment were determined in a univariate and bivariate analysis among asymptomatic 
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pregnant women in Delta State, southern Nigeria. My goal for this study was to extend 
research in the field by generating evidence on the association between asymptomatic 
malaria infection, IPTp-SP compliance, the use of CAM, and pregnancy outcomes among 
parturients in the target population.   
Research Questions and Hypotheses 
 Research Question 1 (RQ1): What is the association between PMPM 
(independent variable 1 [IV1]), IPTp-SP compliance (independent variable 2 [IV2]), the 
use of CAM (independent variable 3 [IV3]), and maternal anemia (dependent variable 
[DV]) among pregnant women in Asaba, Delta State, Nigeria.? 
Null Hypothesis (H01): There is no association between PMPM (IV1), IPTp-SP 
compliance (IV2), the use of CAM (IV3), and maternal anemia (DV) among pregnant 
women in Asaba, Delta State, Nigeria. 
Alternate Hypothesis (H11)): There is an association between PMPM (IV1), IPTp-
SP compliance (IV2), the use of CAM (IV3), and maternal anemia (DV) among pregnant 
women in Asaba, Delta State, Nigeria. 
Research Question 2 (RQ2): What is the association between PMPM (IV1), IPTp-
SP compliance (IV2), the use of CAM (IV3), and baby’s birth weight (DV) among 
pregnant women in Asaba, Delta State, Nigeria? 
Null hypothesis (H02) There is no association between PMPM (IV1), IPTp-SP 
compliance (IV2), the use of CAM (IV3), and baby’s birth weight (DV) among pregnant 
women in Asaba, Delta State, Nigeria. 
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Alternate Hypothesis (H12): There is an association between PMPM (IV1), IPTp-
SP compliance (IV2), the use of CAM (IV3), and baby’s birth weight (DV) among 
pregnant women in Asaba, Delta State, Nigeria. 
Research Question 3 (RQ3): What is the association between PMPM (IV1), IPTp-
SP compliance (IV2), the use of CAM (IV3), and delivery term (DV) among pregnant 
women in Asaba, Delta State, Nigeria? 
Null hypothesis (H03) There is no association between PMPM (IV1), IPTp-SP 
compliance (IV2), the use of CAM (IV3), and delivery term (DV) among pregnant women 
in Asaba, Delta State, Nigeria. 
Alternate hypothesis (H13): There is an association between PMPM (IV1), IPTp-
SP compliance (IV2), the use of CAM (IV3), and delivery term (DV) among pregnant 
women in Asaba, Delta State, Nigeria. 
The Socioecological Model (SEM) Framework 
 The theoretical framework for this study was the SEM. The SEM states that 
health is affected by the interaction between the features of the individual, the 
community, and the environment that includes the physical, social, and political elements 
(Kilanowski, 2017). The CDC has adapted the SEM for various public health endeavors 
to include the scopes of interpersonal, organizational, community, and policy level 
factors (CDC, 2020; Kilanowski, 2017).The SEM is a theory-based framework for 
understanding the multifaceted and interactive effects of personal and environmental 
factors. Some authors have used the SEM to examine various factors that effect, and 
influence disease prevalence, prevention, and control and it yielded valid study outcomes 
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(Bronfenbrenner, 1986; Bronfenbrenner,1989; Bronfenbrenner,1977; Kilanowski, 2017). 
The SEM is also used in the evaluation of programs and policy to ensure safety in the 
environment (Kilanowski, 2017).   
 The SEM recognizes that people’s health choices and decisions are rooted within 
a wide interconnected social and ecological/environmental system that determines the 
health outcome. Therefore, the SEM was an appropriate framework for this study because 
I used it to highlight the social and environmental (residential, health knowledge and 
decisions) risk factors influencing parturients adoption of existing malaria control 
interventions. Using the SEM, I assumed that  there is an association between PMPM 
(biological and an environmental factor), IPTp-SP compliance (personal level 
factor/health decision by parturients), the use of CAM (an interpersonal/relationship-
based factor) and pregnancy outcome (individual, relationship/interpersonal, community, 
and structural level factors) among asymptomatic parturients.  
Nature of the Study 
 This study was a quantitative methodology with a cross-sectional study design 
using binomial logistic regression analysis and the Chi-square test statistics. This 
quantitative study design was appropriate because the survey questions that I designed 
were structured to generate nominal data that can be analyzed quantitatively. To achieve 
the study objectives, I used the SEM theoretical framework, and it was well aligned with 
the variables outlined in the research questions. The hospital data (healthcare facility-
based data) were collected via collaboration with the hospital administration/management 
as a partner organization. The data collection instrument was a paper-based questionnaire 
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answered by the literate subjects or administered by me in a face-to-face approach to the 
subjects who are not literate. This approach could have mitigated missing data and errors. 
I carried out validation with hospital records of subjects to enhance the study validity. 
 The hospital data (variables) included the following outcome, predictors, and 
other variables for univariate and bivariate analysis: 
• Pregnancy outcome variables (dependent/outcome variable; DV) were maternal 
anemia based on the standard hematocrit reader with values of 11 g/dL as 
normal,10 g/dL to 10.9 g/dL as mild, 7 g/dL to 9.9 g/dL as moderate, and less 
than 7 g/dL as severe anemia (WHO, 2011). I recoded the normal anemia values 
as anemia absent (AA) and the mild, moderate, and severe as anemia present 
(AP); baby’s birth weight, above or equals 2.5 kg as normal birth weight (NBW), 
and below 2.5 kg as LBW, preterm and term delivery as less than or equal to 36 
weeks and equal to or greater than 37 weeks, respectively.  
• The predictor/independent/exposure variables (IVs) included PMPM (IV1) as 
positive (presence) placental malaria parasitemia by microscopy (PPMPM) and 
negative (absence) placental malaria parasitemia by microscopy (NPMPM); the 
IPTp-SP (IV2) as to compliant to three or more doses of IPTp-SP during 
pregnancy (adequate) and not compliant as none or less than three doses IPTp-SP 
during pregnancy (inadequate) and use of CAM (IV3) as ‘Yes’  or ‘No’ responses.  
• The other variables for univariates and bivariate analysis included the subject’s 
ITN ownership (Yes, or No), ITN frequent use (Yes, or No), ANC attendance 
(once, twice, more than twice during this pregnancy) gravidae (primigravidae, 
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secundigravidae, and multigravida), age group (18–25, 26–34, 35–42, and 43–49 
years), and educational attainment (none, primary, secondary, tertiary, and 
above).  
I analyzed the data using Statistical Package for Social Sciences (SPSS) version 25. 
The outcome variable and predictor variables were binary variables. I produced an initial 
descriptive statistic in tables and with percentages to describe the frequency distribution 
of the independent and dependent variables. I carried out descriptive statistics to explain 
the study population and features in relation to the relevant variables. I performed a Chi-
square test to estimate the association between the PMPM and each of the enumerated 
risk factors for this study. I checked the logistic regression and Chi-square assumptions 
for all the independent variables and determined the multicollinearity assumption using 
the variance inflation factor (VIF). I determined the model goodness-of-fit using the 
Hosmer-Lemeshow test statistics. I used the binomial logistic regression analysis 
(inferential statistics) to investigate the association between PMPM, IPTp-SP 
compliance, CAM usage, and each of the dependent variables at a P-value of ≤ 0.05 as 
significant. I analyzed RQ1, RQ2, and RQ3 by binomial logistic regression.  
Definitions of Terms Used in the Study 
I adapted some definitions in accordance with the relevant data collection protocols or 
recognized scholarly interpretation. 
Antenatal Care (ANC): The preventive healthcare information, guidance, testing, and 




Asymptomatic malaria patients: carriers of the malaria parasite but with no signs of the 
disease. 
Complementary and alternative medicine (CAM): Herbal, plant-based and traditional 
medicine used by pregnant women against malaria infection.  
Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-
SP): The preventive antimalarial medicine given to pregnant women at routine hospital 
visits. 
Malaria eradication: permanent reduction of the incidence of a particular disease to zero 
levels at the global level via calculated efforts and successive interventions are not 
required.   
Malaria elimination: reduction of the incidence rate of a disease to zero levels in a 
defined geographical area via systematic interventions.  
Malaria infection: The presence of Plasmodium parasites in the blood/tissues of infected 
persons. It requires confirmation by any malaria testing techniques.  
Malaria risk factors: The features or exposure that increases the chances of developing 
malaria infection. 
Parturients: The expectant mothers/pregnant women.            
Polymerase chain reaction (PCR): Molecular laboratory testing for malaria parasites. 
Restriction fragment length polymorphism (RFLP): Another type of molecular testing to 




 I assumed that the proposed healthcare data provided via survey questionnaires 
(primary) and routine hospital (secondary) data are void of 
random/systematic/instrumental error using appropriate sampling methods. I also 
assumed that the subjects who gave consent and participated in this study reside in 
Asaba, Oshimilli South local government area and they all gave honest responses to the 
survey questions. I informed the subjects that I would provide and analyze the data 
without their names and contact. 
I also assumed that the characteristics of the data that was collected via the survey 
questionnaire and routine clinic data were the same across the study location (Asaba). As 
the study sites were randomly selected, there were variability in the samples population 
with the study city being a state capital with varied human populations cutting across 
various levels. I also assumed that subjects represented women from all educational 
levels and residential backgrounds. 
Scope and Delimitations 
 This study was limited to Asaba city in Delta State, southern Nigeria due to the 
constraints of time and cost. In the selection of the variables for this study, it was 
discovered that there was a range of interventions and risk factors of MiP. However, 
those interventions and risk factors have varied outcomes in various locations. It is hoped 
that the findings of this study would enhance existing efforts for a focused intervention 
and addressing specific risk factors that will have a significant outcome for an improved 
pregnancy outcome in the study location and beyond. It is also hoped that the results 
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would be used to influence future intervention policy formulation, elimination strategies, 
and maybe generalizable to the rest of the Delta State and possibly Nigeria.  
Limitations 
 One limitation of this study is that a few of the survey questions depends on self-
reporting by subjects, therefore, recall and misreporting bias may not be ruled out. The 
questionnaire was administered in a face-to-face interview for subjects that are not 
literate by me, while literate subjects filled the questionnaire within few minutes in my 
presence. This approach has the benefit of mitigating the non-response bias but may not 
guarantee anonymity and truthfulness in sensitive question especially on the use of 
herbal/plant medicine during this pregnancy (for concern that the healthcare officials 
does not support the use of CAM). 
Significance of the Study 
 This study is relevant to public health with respect to the study location (southern 
Nigeria) which is a malaria endemic country with a high prevalence of P. falciparum 
which is the most problematic with respect to virulence and resistance to anti-malaria 
drugs; and the population (subjects are immuno-compromised during pregnancy) (Ogola 
et al., 2018; Ruizendaal et al., 2017).  
 There is evidence in the reviewed documents of studies on the prevalence of 
maternal malaria in the study location and other areas but none of the studies determined 
the association between PMPM, pregnancy outcome and other risk factors (ITN 
ownership, ITN frequent use, ANC attendance, gravidae, age group, and educational 
attainment of subjects, as revealed in current literature) across three healthcare facility 
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levels (primary, secondary, and private). The outcome of this study may provide further 
evidence concerning the association between the enumerated variables for this study in 
Asaba, Delta State, Nigeria.  
 This study may have social change implications by providing needed research that 
could help policy makers, community leaders, healthcare organizations, pregnant women, 
and other stakeholders to design informed interventions and preventive approaches, 
including enhanced social support at various levels to reduce the impact of MiP with 
improved pregnancy outcome. This study could lend further support in the control of the 
parasite’s resistance to drugs and other interventions. The P. falciparum resistance is a 
longstanding challenge in the elimination and eradication of malarial diseases, and 
useable information on the predisposing factors (such as use of CAM, ITN frequent use, 
and the refusal to take IPTp-SP) at various locations is not only needed but will improve 
control efforts among asymptomatic pregnant women that are discussed as the parasite 
reservoirs. Current statistics on the impact of the disease on immuno-compromised 
pregnant subjects are striking. WHO and other researchers have called for urgent 
surveillance and epidemiological studies to ascertain the disease burden and enumerate 
risks, and outcome factors to prevent further harm to the affected populations (Agomo et 
al., 2016; Aguzie, 2018; WHO, 2020).  
 This study is an epidemiological analysis to determine the association among 
variables, it could quantify the malaria disease burden among the subjects in the study 
location and the specific risk factors impacting prevention and control in the study 
location could be determined. The outcome of the proposed study may prove critical for 
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the study population and location. Southern Nigeria is in the rain forest zone, and with a 
hot, wet climate, is home to mosquito species (Anopheles gambae and Anopheles 
funestus) (Ogola et al., 2018). They transmit the most virulent strain of the parasite (P.  
falciparum) with a high infectious rate year-round (Ruizendaal et al., 2017). Therefore, 
this study is meaningful, considering the enumerated social and real-world implications 
on women, fetuses, neonates, and society at large.  
Summary and Transition 
 In the introduction of this study, Association between asymptomatic malaria 
infection and pregnancy outcome in Delta State, Nigeria. I reiterated the need for 
epidemiological studies in various locations/regions to reduce MiP based on current 
documents in the field. I highlighted the problem, importance, and significance of the 
study in enhancing the existing intervention approaches including the expected social 
changes that the study findings would have in the malaria endemic community of Asaba. 
I also outlined the methodology that was used to collect both survey questionnaires data 
and the secondary data (hospital record). In addition, a discussion of the study’s 
theoretical framework, within a quantitative cross-sectional study design was presented. 
The anticipated assumptions, limitations, and delimitations to the study and how they 
may be reduced or mitigated were explained.  
In Chapter 2, I presented a literature review that covers the MiP variables and risk factors 
documented in current literature. I provided details on the search strategy, as well as how 
the identified gaps could be addressed in this study. Further, I discussed the theoretical 
orientation (SEM) and how it was synthesized in this study.  
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Chapter 2: Literature Review 
Introduction 
 Malaria in Nigeria is life threatening. Ninety-seven percent of the citizens in this 
region are at risk of the disease. There are various levels of collaborations (individual, 
national and international) to control the disease but has not yielded the expected result. 
Malaria is the second leading cause of death in Africa. The statistics of malaria disease 
morbidity and mortality are highest in Nigeria (Okeke 2012). According to Gontie et al. 
(2020) the documented risk factors of MiP to both mother and the fetus are significant. 
The enumerated risk factors from previous studies on MiP include educational 
attainments, age, ANC visit, gestational age, parity, gravidity, and ITN frequent use. 
Asymptomatic malaria can be deadly, especially among parturients, children, and visitors 
from nonmalarial areas. This is because it is often undetected, therefore not treated. 
Pregnant women are among the most impacted by malaria, because the previously 
acquired immunoglobulin (in endemic settings) is reduced during pregnancy (CDC, 
2020). 
Research evidence in current literature showed that malaria induced-anemia 
accounts for an estimated 10,000 maternal birth in Africa each year (WHO, 2020). The 
infection of the placental by P. falciparum impacts maternal and neonatal exchange 
pattern causing miscarriages, premature births, imparted fetal growth and development 
and death (WHO, 2020).  
The objective of this study was to examine the usage of some malaria 
interventions (IPTp-SP and ITN) and to identify some risk factors (listed in current 
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literature from studies in various locations) that relate to placental malaria infection and 
pregnancy outcome in Asaba, Delta State Nigeria. 
 The purpose of this research was to investigate the association between PMPM, 
IPTp-SP compliance, the use of CAM, and pregnancy outcome (maternal anemia, baby’s 
birth weight, and delivery term) among asymptomatic pregnant women presenting for 
delivery in Asaba, Delta State, Nigeria. In this study, I used a quantitative methodology 
in a cross-sectional study design with deidentified survey paper-based questionnaires and 
healthcare routine data collected from four healthcare facilities in Asaba, Delta State, 
Nigeria. I also determined the subject’s ITN ownership, ITN frequent use, gravidae, age, 
and educational attainments in a univariate and bivariate analysis (with PMPM) among 
asymptomatic pregnant women. In this study, my goal was to extend research in the field 
by generating evidence on the prevalence of placental malaria disease burden, and 
prevailing risk factors in the study population and location.  
 In this chapter, I described the reviewed literature related to maternal malaria and 
pregnancy outcomes as well as existing interventions on malaria and their 
usage/utilization. I examined the gaps in the current knowledge base on maternal malaria 
parasitemia, use of CAM, and the risk factors related to the usage of malaria interventions 
by pregnant women. The connection between maternal malaria and malaria transmission 
based on gravidae and educational attainments of parturients were discussed. Further, this 
study provided explanation of the background of the study, problem statement, purpose, 
nature of the study, scope, delimitation, limitations of the study, and the significance of 
the study in this chapter. A description of the available information on the epidemiology 
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of malaria and the biology of the malaria vector and parasite were explored. I concluded 
this chapter by explaining the SEM framework as the foundational model selected for this 
study. 
Literature Search Strategies 
 I used the Google search engine for this literature review. The keywords searched 
were malaria, Plasmodium, peripheral malaria, placenta malaria, parasite-resistance, 
pregnancy, pregnancy outcome, and mosquito in the databases of Walden University 
Health Sciences (Medline, ProQuest, Ebscohost, Google Scholar, PubMed, PLoS ONE, 
Science Direct). The approach used for searching for the relevant literature was premised 
on current literature related to maternal malaria, pregnancy outcome, and the SEM 
framework. My focus on the literature search was on current (within the past five years) 
scholarly peer-reviewed articles on journals, academic books, government, and 
organization publications. However, a few older articles that are foundational to the study 
were included. 
The inclusion criteria for the documentation were: 
1. Research publication dates from 2016 to 2021 (excluding foundational documents).  
2. Peer-reviewed journal publications or governmental agency documents.  
3. Journal articles that met the target population (parturients in Asaba, Delta State, 
southern, Nigeria, SSA, Africa).  
4. Journal articles that discussed malaria/MiP. 
 The exclusion criteria were as follows:  
1. The literature did not support this study (MiP).  
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2. The literature did not meet the inclusion criteria. 
 3. The literature did not comply with the target population and year of publication.  
4. The literature did not highlight the theme of this study. 
The Socioecological Model (SEM) 
 I premised this study on the SEM. This model explains that personal health 
behavior is determined by multilevel factors, including personal level (e.g., age, sex at 
birth), interpersonal level (e.g., family, community), and system level (e.g., local, state, 
and national government levels, civil society, NGOs, such as roll back malaria initiative, 
president malaria initiative, malaria elimination and control group) (Awuah et al., 2018; 
Kumar et al., 2012). These factors impact a person's decision to engage the health system 
(Revenson et al., 1991). Wright, (2016) stated that positive social support can strengthen 
health behavioral change. My goal in this study was to examine how the intersection of 
these factors is associated with PMPM and pregnancy outcome, specifically, the usage of 
the malaria interventions recommended by the ANC. Awuah et al. (2018) stated that low 
socioeconomic status (SES) is strongly associated with using an alternative treatment for 
malaria (Aikins, 2005; Chuma et al., 2010). Therefore, building on the premise of Awuah 
and colleagues, it is possible that multilevel factors, such as economic status, gravidae, 
age, (individual level), social support, use of CAM, (interpersonal level), health 
insurance, PMPM, ANC attendance, and place of residence (system level), affect PMP 
and pregnancy outcome. 
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Application of the Theories in Previous Study Similar to This Study 
 The SEM is a well-established theoretical framework in global health, 
international development, and communication (Bronfenbrenner,1999; Bronfenbrenner, 
1979; McLeroy et al., 1988; Morris, 1975; UNICEF, 2018). The SEM is at the forefront 
of communication for development (C4D) programs. It is UNICEF’S major framework 
for the social and behavioral change communication (SBCC) program (UNICEF, 2018).  
The integration of multilevel engagement of groups and stakeholders enhances health 
communication and adoption of interventions (Schiavo et al., 2020; UNICEF, 2018). The 
SEM has been successfully used in public health both locally and internationally 
(Schiavo et al., 2020). For example, the UNICEF routine immunization program in 
Kyrgyzstan to increase uptake of immunization was grounded in the SEM. The SEM is 
centered on the fact that a person’s health behavior and decision is a function of the 
interaction between the social, individual, structural, and the environment that promotes 
behavior change (Morris, 1975).  
 Schiavo et al. (2020) stated that the SEM can be used in both quantitative and 
qualitative studies. This study was quantitative in nature; hence it was appropriate to use 
the SEM as a framework. The SEM has the advantage of focusing on a multilevel factor; 
making it most appropriate in the public health field (Bronfenbrenner, 1999;  
Bronfenbrenner, 1979; McLeroy et al., 1988). Schiavo et al. (2020) stated that the SEM is 
beneficial in studies involving low health literacy populations. Robinson (2008), in the 
literature review study on improving fruit and vegetable consumption by the African 
Americans with low SES, stated that the SEM framework was appropriate for most 
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public health studies due to the complex interaction of various factors. The use of the 
SEM in the study on the factors limiting contraceptive use by adolescents in Nigeria by 
Ezenwaka et al. (2020) yielded a valid contribution to knowledge.  
Rationale for the Selection of the SEM framework 
 Although there is evidence on maternal malaria parasitemia in SSA, no study has 
determined the association between PMPM, IPTp-SP compliance, use of CAM with 
pregnancy outcome in Nigeria using primary and hospital routine data across three 
healthcare facility levels (primary, secondary, and tertiary). This study was used to 
ascertain some risk factors of placental malaria in the study location and the parturients 
most at risk based on IPTp-SP compliance, CAM usage, gravidae, ITN ownership, ITN 
frequent use, and educational attainments.  
 I enumerated the risk factors for further investigation based on the evidence in the 
current literature. The study outcome may have social change implications via targeted 
adjustment at the personal, interpersonal, community, and system level of malaria 








Source: U.S Center for Disease Control and Prevention, (2020); 
https://www.cdc.gov/violenceprevention/overview/social-ecologicalmodel.html. 
 The mixed SES of the subjects (pregnant women) implies that their understanding 
of the utilization of the available intervention is poor, hence the need for proper guidance 
and support from the ANC staff of the hospital and the malaria stakeholders. This aligned 
with the relationship and community level of the social support element of the SEM 
model. Further, the research on determining the association between asymptomatic 
PMPM, IPTp-SP compliance, use of CAM, and pregnancy outcome among pregnant 
women in Asaba, Delta State, Nigeria, is a match with the SEM orientation. The SEM is 
a theoretical framework involving all stakeholders (Bronfenbrenner, 1986; 
Bronfenbrenner, 1989; Bronfenbrenner, 1977; Kilanowski, 2017). In this study, it 
involves the government, communities, organizations, malaria control partners, 
participants, family, friends, and healthcare staff of the ANC.  
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 The observed interactions at the various levels of relationship are an ideal system 
thinking approach to enhance personal, relationship, community, organizational, and 
system interaction for goal attainment and social support to parturients. The SEM is a 
suitable mitigation for the weaknesses/inadequacies of participants (Bronfenbrenner, 
1986; Bronfenbrenner, 1989; Bronfenbrenner, 1977; Kilanowski, 2017; Schiavo et al., 
2020). In this study, it pertains to health decisions, compliance to IPTp-SP and ITN 
frequent use, low educational attainments, poor residential location, and housing 
structures to achieve improved pregnancy outcome Moreover, this study could influence 
positive social change by mitigating the malaria surge in this group of the 
immunocompromised persons. Awuah et al.’s (2018) study on the determination of the 
risk factors of malaria infection seeking behavior among the low SES community in 
Ghana was grounded in the SEM. It produced valid study findings. The outcome of this 
research could yield useful information for malaria prevention and elimination programs 
in Asaba, Delta State, southern Nigeria. The adoption of the SEM framework in this 
study could achieve effective teamwork in controlling malaria among parturients in the 
target location. The outcome of this study could be applied to a similar population in 
other locations in the SSA region. 
Literature Review Related to Key Variables and Concepts 
Global and National Epidemiology of Malaria 
 According to the WHO, there were 228 million malaria cases in 2018 compared 
to 231 million cases in 2017; with 405,000 deaths in 2018 compared to 416,000 in 2017 
(WHO, 2019). The economic cost of managing malaria has been rising for years and was 
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$2.7 million in 2018. The counterpart funding from endemic nations was $900 million, 
which is 30% of the total funding (CDC, 2020; WHO, 2020). The WHO Africa region 
bears 93% of cases and 94% of deaths due to malaria worldwide. The P. falciparum 
(mostly in the Africa regions) and P. vivax (mostly in the Americas regions) species are 
of the highest threat to humans with P. falciparum accounting for 99.7% cases in the 
WHO Africa region, 50% in the WHO South-east Asia, 71% in the Eastern 
Mediterranean, and 65% in the Western Pacific regions (CDC, 2020; WHO, 2020). 
Epidemiology of Maternal Malaria 
 The WHO, (2020) reported that malaria is a preventable and treatable/curable 
infectious disease of humans, the causative agent of which is a protozoan parasite 
(Plasmodium species). Both the vector and parasite of malaria have been evolving for 
decades, and several efforts by scientists and global health bodies to eradicate the disease 
have not yielded complete success (Talakpo et al., 2019).  
 Buh et al. (2019) stated that the malaria infection caused by P. falciparum 
infection is the most prevalent in the SSA. It accounts for adverse pregnancy outcomes. 
Parturients have a higher susceptibility to malaria disease compared to their non-pregnant 
counterparts. The reinfection, development of a complication, and mortality from malaria 
disease are common among parturients (Knott, 2016; WHO, 2017). The complications 
include intrauterine growth retardation (IUGR), preterm delivery, anemia, hypoglycemia 
oedema, fetal distress, spontaneous abortion, LBW, neonatal mortality and maternal 
death. While the associated risk factors enumerated in various studies are parturient’s 
age, parity/gravidae, subject’s residential location, maternal income level, malaria in 
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pregnancy awareness, housing structure, IPTp-SP usage, and ANC attendance (Azizi et 
al., 2018; Buh et al., 2019; WHO, 2018).    
The Route and Biology of the Mosquito and Plasmodium Parasite 
The Route of Malaria Transmission 
 The infected Anopheles mosquitoes are the vector of the Plasmodium species 
parasite. The parasite can be transmitted via blood transmission, organ transplant, sharing 
of infected needles/syringes, and neonates can contact congenital malaria via maternal 
placental (CDC, 2020; WHO, 2020). The transmission intensity of malaria infection is 
subject to the parasite, vector, human, and environmental factors. The Anopheles 
mosquitoes, after a blood meal, will lay eggs in water, which hatch into larvae and 
subsequently develops into the adult mosquito. The A. gambiae and A. funestus prefers 
clean and clear water for their eggs (WHO, 2020). Further, WHO (2020) stated that the 
Africa Anopheles species prefers the human to animal host hence the high prevalence of 
the disease in that region. The mosquito lifespan, climatic conditions (pattern of rainfall, 
temperature, and humidity) are also determinants of malaria transmission.  
The Biology of the Plasmodium Parasite 
 The CDC (2020) reported 176 species of Plasmodium species that infect 
vertebrates, of which 4 (P. falciparum, P. vivux, P. ovale, and P. malariae) are true 
parasites of humans. The P. knowelsi are sometimes reported to infect humans but its 
transmission to humans via the mosquito vector without the monkey (intermediate host) 
is not established. Hence P. knowelsi is considered a zoonotic malaria. According to 
Talakpo et al. (2019), P. falciparum and P. vivax have the greatest health implication. It 
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was reported that in 2018, P. falciparum accounted for 99.7% of malaria cases in the 
WHO African region, while P. vivax is the prevalent species in the WHO American 
region (CDC, 2020; Talakpo et al., 2019).  
 The life cycle of the Plasmodium parasite involves the sexual and asexual forms 
in a different host. The sexual stage of the parasite occurs in the vector (Anopheles 
species), while the asexual phase takes place in the human host and humans are the 
intermediate host of the parasite. According to Talakpo et al. (2019), asymptomatic 
malaria infection can persist in a human host for three to five years and may recrudesce 
(failure of antimalaria drugs to clear parasite due to parasite resistance to malaria drugs). 
The persistence of the merozoites and hepatocytes can lead to a relapse of the infection 
several months or years after the initial infection. The occurrence of relapse is common in 
P. falciparum infection resulting in high parasitemia. The Plasmodium species are 
complex parasites with a complicated lifecycle, which can evade the host immune 
responses via morphological and antigenic changes. The Plasmodium proteins are 
polymorphic with redundant functions (Talakpo et al., 2019), this parasitic disease 
accounts for the highest hepatic stage of the life cycle. The hepatocytes multiply and 
differentiate into the schizonts (made up of the numerous hepatic merozoites). The 
merozoites invade the red blood cells (RBCs) for the erythrocytic stage. Some merozoites 
in the RBCs transform into the gametocytes, which are picked up by the mosquito during 
a blood meal (Talakpo et al., 2019). According to Talakpo et al. (2019), all malaria 
parasite infections in humans leads to the upsurge of the RBCs (erythrocytes). When the 
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infection is untreated, it may recrudesce (appearance of malaria parasitemia from residual 
blood-stage parasite following failed treatment), depending on the Plasmodium species. 
The Biology of the Plasmodium Parasite in the Vector (Mosquito)  
 According to the CDC (2020), the global impact of malaria is significant. There 
are about 400 species, of which 30 are vectors of public health importance (WHO, 2020). 
The A. gambiae and A. funestus are the most efficient malaria vectors in the world and 
are the most prevalent in Africa (Nureye and Assefa, 2020). While the predominant 
parasite species of malaria is P. falciparum (CDC, 2020; WHO, 2020). The malaria 
parasite is transmitted via the bite of an infected female Anopheles mosquito species.  
Anopheles mosquitoes lay their eggs in water, which hatch into larvae, eventually 
emerging as adult mosquitoes. The female mosquitoes seek a blood meal to nurture their 
eggs. Each species of Anopheles mosquito has its preferred aquatic habitat. For example, 
some prefer small, shallow collections of freshwaters, such as puddles and hoof prints, 
which are abundant during the rainy season in tropical countries (WHO, 2020).  
The sporogony, or sexual phase of the Plasmodium life cycle occurs in the female 
Anopheles mosquito. The male and female gametocytes are picked up from the blood of 
the human host during the blood meal by the Anopheles mosquito. The blood meal is 
required for the development of their eggs (Onyemaechi and Malann, 2020). According 
to the CDC (2020), the male and female gametocytes (microgametocytes and 
macrogametocytes), respectively, are taken by a female Anopheles mosquito during a 
vertebrate blood meal. In the sporogonic cycle (parasite multiplication in the mosquito) 
and the mosquito’s stomach, the fusion of the male and female gametocytes generates the 
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zygotes that become ookinetes (motile and elongated). The ookinetes invade the midgut 
wall of the mosquito and develop into the oocysts. The oocysts grow, rupture, and release 
sporozoites, which make their way to the mosquito’s salivary glands for inoculation into 
a new human host (or other vertebrates host) during a blood meal to continue the malaria 
life cycle (CDC, 2020).  
The Plasmodium Life Cycle in Humans  
 According to Nureye and Assefa (2020), the Plasmodium species is a protozoan 
blood apicomplexan parasite that infects man via the bite of an infected female Anopheles 
mosquito species. The malaria infection by P. vivax also occurs throughout Africa but 
with low infectivity due to the absence of the Duffy gene among the African people. 
However, this report is controversial and may require further studies to validate (Nureye 
& Assefa, 2020). 
 The sexual developmental stage of Plasmodium occurs in humans after the 
inoculation of the sporozoites during blood meal via the bite of an infected female 
anopheles’ mosquito (A. gambiae and A. funestus) (CDC, 2020). The sporozoites invade 
the RBCs and after 30 minutes of blood circulation, enter the liver (hepatocytes); the 
asexual stage in the human host occurs in the liver (hepatocytes) and the RBCs. These 
sporozoites migrate to the liver and mature into schizonts that rupture and release the 
merozoites. These merozoites invade the erythrocytes to undergo the asexual phase of 
development. The ring stage trophozoites mature into schizonts, which rupture to release 
the merozoites, of which some become the gametocytes (male and female). The RBSs 
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ruptures due to the parasites causing fever, chills, and other symptoms of the disease 
(CDC, 2020; Talakpo et al., 2019).  
Figure 2. 
 
Diagram of the Plasmodium Life Cycle 
 
SOURCE: U.S. Centers for Disease Control and Prevention  (2020); 
http://www.cdc.gov/malaria/about/biology/ 
Malaria Diagnosis/Testing Techniques 
 The diagnosis of malaria is via the identification of parasite antibodies from the 
host blood specimen. The direct diagnostic methods are RDT, microscopy, and molecular 
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tests, while indirect methods are indirect immunofluorescence antibody (IFA) and ELISA 
diagnosis (Talakpo et al., 2019). However, the gold standard diagnostic method is light 
microscopy of stained blood films by giemsa. The light microscopy can detect a malaria 
infection with 10 to 100 parasite/µl. The professional expertise of the microscopist is a 
determinant of the sensitivity of this method (Talakpo et al., 2019). The diagnosis of P. 
falciparum in pregnancy includes peripheral and placental blood microscopy, antigen 
detection tests, polymerase chain reaction (PCR), and placental histology. Placental 
histology and PCR are the most sensitive in detecting malaria parasitemia (Agomo et al., 
2016; Aguzie, 2018; Lufelu et al., 2017).  
 The rapid diagnostic test (RDT) is an immunochromatographic test used to detect 
the malaria parasite antigen in the blood specimen. It is void of technical expertise 
requirements. The WHO recommended the RDT as the first choice of test in high burden 
areas of malaria infection, but the result should be validated by microscopy. The 
sensitivity is subject to the selected antigen represented in the test. The RDT for detecting 
antigens in the blood is immunochromatographic tests to prove the presence of parasite 
antigens. No electrical equipment, special training, or skills are required to perform these 
tests. The WHO now recommends RDT as the first choice for malaria diagnosis across 
the world in all malaria-endemic areas. The sensitivity of the antigen test varies 
depending on the selected antigens represented in the test. For some RDTs, it is 50 to 100 
parasites/µL (Talakpo et al., 2019; WHO, 2020).   
 PCR is another method in the detection of malaria. This method is more sensitive 
and more specific than all conventional methods in the detection of malaria. It can detect 
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below one parasite/µL. PCR test confirms the presence of parasitic nucleic acid. PCR 
results are often not available as fast enough to be useful in malaria diagnosis in endemic 
areas. However, this method helps identify Plasmodium species after diagnosis by 
microscopy or RDT test in laboratories that lack microscopic experts. Additionally, PCR 
is useful for the monitoring of patients receiving antimalaria treatment. Indirect methods 
are used to demonstrate antibodies to malaria-causing agents. Such methods are used in 
testing people who have been or might be at risk of malaria, such as blood donors and 
pregnant women. The method is based on an indirect IFA or an Enzyme-linked 
Immunosorbent Assay (ELISA) (Talakpo et al., 2019).  
Malaria Transmission 
 Segun et al. (2020) stated that the recent climate changes have adverse 
consequences on public health in Africa and other tropical regions of the world. Some 
others, including Talakpo et al. (2019) reported that climate changes favor the spread of 
vector-borne diseases such as malaria, Zika virus, and dengue fever. This spread is 
because the parasite life cycle and development in the vector are enhanced in the vector 
at certain climatic settings. The 18oC to 30oC (65oF to 86oF) temperature with 60% to 
90% humidity is favorable to the breeding of the plasmodium parasites (Chu & White, 
2016). The eggs and larvae stages of the mosquito require water, while the adult needs an 
appropriate temperature for growth and development. Further, Segun et al. (2020), 
suggests that malaria transmission is more intense in places where the mosquito lifespan 
is longer as the parasite has a longer development period inside the mosquito host, and 
where it prefers to bite humans rather than other animals. The long lifespan and strong 
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human-biting habit of the African vector species is the principal reason why 
approximately 90% of the world/global malaria cases are in Africa. The transmission of 
the malaria parasite also depends on climatic conditions that may affect the number and 
survival of mosquitoes, such as rainfall patterns, temperature, and humidity. In many 
places, the transmission is seasonal, with the peak during and just after the rainy season 
(Segun et al., 2020). 
 Malaria epidemics can occur when climate and other conditions suddenly favor 
transmission in areas where people have little or no immunity to malaria. They can also 
occur when people with low immunity move into areas with intense malaria transmission, 
for instance, for work or as refugees (Segun et al., 2020). According to WHO (2020), 
human immunity in malaria infection is another important factor, especially among adults 
in areas of moderate or intense transmission conditions. Partial immunity is developed 
over years of exposure, and while it never provides complete protection, it does reduce 
the risk that malaria infection will cause severe disease. For this reason, most malaria 
deaths in Africa occur in young children, parturients, and HIV patients. In contrast, in 
areas with less transmission and low immunity, all age groups are at risk (WHO, 2020). 
Onyemaechi and Malann (2020) reported that primigravidae show a higher prevalence of 
malaria than multigravidae and concluded that environmental conditions (temperature, 
relative humidity, and rainfall) are strongly associated with malaria incidence rate among 
the gravidae.  
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Malaria in Pregnancy (Peripheral and Placental Malaria) 
 Placenta malaria is the presence of the Plasmodium parasite in an infected 
erythrocyte or the parasite pigment/haemozoin in the intervillous spaces of the placenta. 
The developed asexual forms of the P. falciparum sequester in the placenta and evaded 
the host splenic clearance. Placental malaria infection is mostly asymptomatic, 
submicroscopic, and undetected by peripheral analysis, thereby complicating treatment 
(Lufelu et al., 2017).  
 Ouedraogo et al. (2012) reported that P. falciparum malaria infection is mostly 
asymptomatic in a high burden malaria area and usually yields maternal anemia, 
placental, and cord blood parasitemia among primigravidae and secundigravidae. 
Placental malaria does not imply the presence of peripheral malaria. Placental malaria is 
related to high parasitemia and repeated episodes of the parasites during pregnancy. 
Ouedraogo et al. (2012) reported a 19.6% prevalence of placental malaria in Burkina 
Faso and that maternal peripheral blood parasitemia is associated with umbilical cord 
parasitemia. The identified risk factors are high-density placental and peripheral 
parasitemia, including primigravidae status. These authors concluded that the low level of 
umbilical cord parasitemia implied that neonatal infection could be during delivery.  
Wylie et al. (2020) stated that other effects of malaria in pregnancy include congenital 
infection and neonatal death. The high vulnerability of pregnant women to P. falciparum 
malaria infection is due to the ability of the iRBCs to sequester in the placental with 
adverse consequences on pregnancy outcome via the obstruction of maternal and 
neonatal exchange system. Also, there is evidence of drug failures due to parasite 
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resistance to anti-malaria medicine. Further, the sequestered parasite in the placenta could 
be released intermittently into the peripheral blood and cause recurrent maternal infection 
(Wylie et al., 2020). 
 Anorue et al. (2020) reported a high prevalence of 65.8% of placental malaria by 
microscopy in Asaba, Delta State, southern Nigeria, while Achu et al. (2020) gave a 
prevalence of 8.3% and 17.7% by RDT and microscopy, respectively, of peripheral 
maternal malaria in the same location. Further, Olukosi and Afolabi (2018) reported a 
prevalence of 19.5% and 81.4% for peripheral malaria and anemia, respectively, in 
Lagos, southwest Nigeria. These authors stated that the subjects with anemia are more 
likely to have malaria infection than those without anemia. Aliyu et al. (2017) reported a 
prevalence of 22.4% of malaria in their study exploring the predictors of malaria  
parasitemia and antimalarial resistance forms of Plasmodium isolates in Kaduna State, 
northern Nigeria. These researchers also reported that significant isolates of P. 
falciparum exhibited multidrug resistance against several antimalarial agents.  
Some researchers documented the presence of malaria parasites in the placenta of 
asymptomatic pregnant women with peripheral parasitemia undetected by microscopy 
(Omer et al., 2017; Rogerson et al., 2018). There is a gap in current knowledge that this 
study filled by carrying out a bivariate analysis PMPM with potential risk factors 
(documented in some literature from other locations).  
 Omer et al. (2017) reported a high prevalence (58.9%) of placenta malaria with 
consequences of maternal anemia and LBW of the neonates in their study area (Uganda). 
These same authors affirmed that positive peripheral malaria at delivery was associated 
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with LBW among the subject in their study. Moreover, De Beaudrap et al. (2016) 
reported that in Uganda, that the infants of mothers with malaria-infected placenta are at 
increased risk of LBW and preterm deliveries compared to babies from mothers with 
peripheral malaria infection. These authors reported that the time of the disease during 
pregnancy was a determining factor. Maternal malaria infection in the last 12 weeks to 
delivery is at increased risk of adverse outcomes for the mother and baby. De Beaudrap et 
al. (2016) concluded that placenta malaria impacts a baby’s growth in the first year of life 
but that effective malaria treatment early in pregnancy did not yield adverse fetal and 
neonatal outcomes.   
 Goyal et al. (2016) stated that 25% of parturients have evidence of placental 
malaria at delivery in SSA, and in the low malaria setting, gravida is not associated with 
parasitemia and pregnancy outcome. In Africa, the prevalence of maternal malaria 
disease (peripheral and placental) is 27.8% based on microscopy. Goyal et al. (2016) 
stated a need to determine prevalence based on high sensitivity and specificity testing 
techniques such as PCR and histology. The HIV parturient is at increased risk of malaria 
infection, while MiP increases the HIV viral load of the subject. Parturient is at increased 
risk of P. vivax and P. falciparum. There is no evidence of mixed (more than one specie 
of the Plasmodium parasites) infection, but it decreases with increasing age and parity.  
 A study by Quakyi et al. (2019) using a cross-sectional hospital-based survey 
showed that low-density parasitemia is common in high burden malaria areas. Kapisi et 
al. (2017) stated that a high malaria burden is associated with placental malaria and 
adverse pregnancy outcome. It was a randomized control trial of IPTp-SP with an 
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assessment of placental malaria and pregnancy outcomes. These authors reported an 
association between high malaria burden in pregnancy with primigravidae, lower 
household, and IPTp-SP usage. LAMB was more sensitive in measuring placental 
malaria than microscopy and histopathology. Besides, they stated that placental malaria is 
associated with adverse pregnancy outcomes (Kapisi et al., 2017).  
Maternal Malaria and Pregnancy Outcome 
Anemia 
 The definition of anemia varies with the trimester of pregnancy. The value of 
<11g/dL in the first and last (third) trimester of pregnancy are considered anemic while 
10g/dL–10.5g/dL in the second trimester is termed to be anemic (CDC, 1998; Renzo et 
al., 2015; Rouamba, et al., 2021; Tabrizi & Barjasteh, 2015).    
 White (2018) reported from their review study that anemia is strongly associated 
with malaria infection in pregnancy. The risk of anemia increases with increasing 
pregnancy development. These authors stated that high maternal malaria parasitemia is 
associated with fetal and neonatal anemia among parturients with asymptomatic malaria 
infection resulting in adverse maternal and fetal outcomes (White, 2018).  
Vasquez et al. (2020) stated that parturient in their first and second trimester is more 
likely to be infected with the malaria parasites. Also, asymptomatic, and submicroscopic 
infections relate to adverse pregnancy outcomes. These authors reported that parturients 
with malaria parasitemia have a two-fold higher risk of anemia than non-pregnant 
counterparts, and those with maternal malaria has a two-fold higher risk of anemia, which 
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is associated with maternal morbidity and death, including neonatal death (Vasquez et al., 
2020). 
Stillbirth and Preterm Deliveries 
 Moore et al. (2017), in their system and meta-analysis studies, confirmed that MiP 
is the primary cause of stillbirth among parturients. These authors stated that placental 
malaria caused by P. falciparum has the highest of stillbirth/preterm delivery compared 
to malaria infection by other species of Plasmodium. Besides, the intensity of P. 
falciparum transmission influences stillbirths/miscarriages. Moore et al. (2017) stated 
that there would be a likely increase in the clinical and adverse pregnancy outcome 
including stillbirth due to the expected further reduction in acquired immunity among the 
secundigravida and multigravida as countries attain the elimination and eradication phase 
of malaria control; hence, more studies on malaria among parturient are required for the 
optimal protection of this population. 
Treatment and Other Interventions on Maternal Malaria 
The Drug Treatment of Malaria in Pregnancy  
 The treatment of malaria has evolved over the years; it dates to the second century 
in China with a sweet sage wort plant called Qinghai. Later, the Spanish in Peru treated it 
with the bark of the cinchona tree. The French chemists Pierre Joseph Pelletie and Joseph 
Bienaime Caventou isolated quinine as the active ingredient against malaria parasite from 
the Cinchona tree; in 1970, Chinese scientists isolated artemisinin from the Artemisia 
annua plant, which is still potent today (Talakpo et al., 2019). The WHO recommended 
the ACT combination therapy against malaria due to the malaria parasite’s resistance to 
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chloroquine, sulfadoxine-pyrimethamine, and amodiaquine (Talakpo et al., 2019; WHO, 
2018). 
The Use of CAM for Malaria Treatment 
 The widespread use of CAM by parturients is well documented in the literature 
(Quakyi et al., 2019). According to WHO, (2013) herbal medicine are products of herbs 
and plants in the form of liquid, powder, or other formulations. Mothupi (2014) reported 
from the study on the use of herbal medicine by pregnant women in Kenya that 12% of 
them use herbal medicine while 20% use it simultaneously with the western medicine 
(IPTp-SP) they received from the ANC clinic. The author concluded that the ANC 
officials are unaware of such acts by their patience and recommended the need to train 
the parturients on the possible interaction effect of such combination. The author further 
stated that there is a need to determine the association between herbal medicine and 
pregnancy outcome.  
 Ogbonnaya et al. (2019) stated that the belief that herbal medicine is safe and 
effective is widespread among pregnant women in Nigeria. Besides, Nergard et al. (2015) 
reported that the use of medicinal plants for the treatment of malaria by pregnant women 
is a growing concern in Mali and other African countries.  
The determination of the CAM association with the pregnancy outcome variables for this 
study is a necessary contribution to the existing knowledge base. There is no current 
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documentation on the possible association between PMP, CAM, and pregnancy outcome 
in the study location. 
 Other Interventions on MiP (ITNs, IRS, and IPTp-SP) 
 According to Yaya et al. (2018), SSA bears the highest burden of malaria 
infection. MiP is a key preventable cause of maternal and neonatal morbidity and death 
with unacceptable statistics. Despite, this evidence, the uptake, and usage of the existing 
interventions are far below the acceptable threshold in the region. The uptake of malaria 
intervention remains unsatisfactory and is void of equity in distribution across countries 
in the SSA (Yaya et al., 2018).  
The ITNs and IRS are cost-effective vector control approaches, but the IRS 
requires extensive coverage to be effective in vector control. The malaria situation in 
Nigeria requires all stakeholders sincere and urgent attention to accelerate the malaria 
elimination and eradication plan.  
IPTp-SP. 
 The Nigeria Federal Ministry of Health adopted the use of IPTp-SP in 2005 for 
malaria prevention and control (Igboeli et al., 2018). The WHO recommended the 
evaluation and monitoring of IPTp-SP association with pregnancy outcome as an 
assessment for the continued use of the medicine in pregnancy (Igboeli et al., 2018).  
Yaya et al. (2018) evaluated the prevalence and pattern of IPTp-SP uptake in some 
countries in the SSA and concluded that the prevalence is significantly associated with 
maternal education and family wealth status. Yaya et al. (2018) stated that the barriers to 
the usage of IPTp-SP include healthcare, economic, individual and community level, late 
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ANC registration, and poor knowledge. Most countries in Asia and South America are 
now on malaria elimination; meanwhile, the SSA is far behind with persistent bottlenecks 
in adopting existing preventive measures. These authors reported low prevalence and 
usage of IPTp-SP in SSA. They suggested a need to address the policy, structural, and 
socio-economic status (SES) factors accounting for such outcomes in the SSA region. 
They recommended the need to identify the potential barriers to the usage of IPTp-SP 
among parturients in the study location (Yaya et al., 2018).  
 In a study by Buh et al. (2019) from Sierra Leone, it was found that there was a 
higher likelihood of IPTp-SP uptake among parturients with higher education, higher 
parity of greater than four, and adequate ANC visit during pregnancy. These authors 
concluded that the uptake of IPTp-SP among rural dwellers was higher compared to the 
urban dwellers. Other authors gave contrary evidence from their studies (Amoakoh-
Coleman et al., 2020; Yaya et al., 2018). It implies that there is geographical and 
locational specificity in the adoption and uptake of interventions. 
 Amoakoh-Coleman et al. (2020) detailed factors influencing the distribution and 
uptake of IPTp-SP in the SSA to includes maternal education, the onset of ANC visit, 
maternal SES, and demographic variables, and health knowledge. Also, the type of 
healthcare facility (primary, secondary, public, and tertiary), number of ANC attendance 
and health insurance status influences the uptake of IPTp-SP among parturients 
(Amoakoh-Coleman et al., 2020).  
 The WHO recommended that IPTp-SP should be taken monthly from 14 weeks of 
gestation for a minimum of three doses before delivery. The dosage was reviewed to five 
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doses or more before delivery due to the extensive wide reports of parasite’s resistance to 
anti-malaria medicine. The observation from various reports in the SSA revealed that the 
uptake of IPTp-SP is far below expectations (Amoakoh-Coleman et al., 2020).   
 The review study by Roman et al. (2019) reported a low prevalence of IPTp-SP 
uptake, and the outcome was attributed to poor implementation approaches, enforcement, 
leadership, and healthcare problems. These authors suggested that there is a need to 
ascertain the factors predicting the uptake of IPTp-SP in SSA countries to develop 
appropriate interventions based on location. Therefore, the existing evidence from studies 
on the association between IPTp-SP uptake with education and other risk factors in 
literature is inconsistent. A study by Yaya et al. (2018) yielded an inverse outcome, 
whereas the study by Buh et al. (2019) reported that higher maternal education is 
associated with an adequate dosage of IPTp-SP. Yaya et al. (2018) recommended the 
need to determine the barriers to IPTp-SP uptake in the SSA and that they are region 
specific. Quakyi et al. (2019) reported a strong association between an increase in IPTp-
SP uptake and increased birth weight. An IPTp-SP greater than three doses improve birth 
weight by 0.165kg. Some studies reported on the effectiveness of the treatment and 
preventive effect of IPTp-SP on parturients.  
 Some studies reported that the Plasmodium parasite detection difference between 
microscopy and PCR is significant. For example, Quakyi et al. (2019), reported low 
uptake of IPTp-SP in Ghana compared to ANC attendance. These authors concluded via 
their study on plasma level measurement of parturients that the WHO policy on greater 
than three doses of IPTp-SP is well implemented in their study population. They stated 
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that malaria infection is particularly threatening in the first and second trimester and 
before ANC registration; therefore, interventions such as malaria vaccine are necessary. 
Other studies stated that greater than three doses of IPTp-SP doses improve birth weight 
compared to the previous two dose regimes (Anchang et al., 2020). Quakyi et al. (2020) 
recommended a future study to determine the impact of the prolonged use of IPTp-SP on 
the fetus and neonates.  
 Igboeli et al.’s (2018) study was to ascertain the prevalence of LBW between the 
pre- IPTp-SP (2000 to 2004) and post-IPTp-SP (2005 to 2010) for various gravidae in 
southern Nigeria using retrospective hospital register. The authors reported a slight 
positive difference in birth weight in the post-IPTp-SP compared to the pre-IPTp-SP, 
with the primigravidae showing higher prevalence and risk of LBW in both eras.  
Other risk factors for LBW include maternal smoking status, high blood pressure 
(HBP)/pre-eclampsia, maternal nutritional status, number of ANC visits, baby’s gender, 
maternal anemia, age, HIV, anemia, and pre-eclampsia being gravidae specific, affecting 
primigravidae mostly. One outcome of the study by Igboeli et al. (2018) was that there 
was no reduction in the risk of LBW in the primigravidae when compared with the 
multigravida despite the policy change in IPTp-SP dosage. The authors concluded that 
the policy change of IPTp-SP on the prevalence of LBW was not positive in their study 
area.  
 Oluwagbemiga et al. (2018) study was in southwestern Nigeria (Oyo state) to 
ascertain the factors influencing the usage of IPTp-SP in pregnancy. The authors reported 
that delayed registration for ANC and stock out of IPTp-SP were the observed factors 
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limiting the use of IPTp-SP medicine. It showed a low usage of IPTp-SP in the study 
locations. The authors recommended the implementation of the direct observation 
therapy (DOT) approach in IPTp-SP administration among the ANC subjects.  
Anchang et al. (2020) accessed the coverage and effects of IPTp-SP 3-dose to 2-dose 
regimen on placental malaria parasitemia and LBW in Cameroun via a cross-sectional 
study design. The authors concluded that IPTp-SP of three or more doses was ineffective 
in preventing placental malaria. However, IPTp-SP was associated with increased birth 
weight and hemoglobin levels.  
Insecticide Treated Net (ITN) 
 Sidiki et al. (2020) stated that hindrances to ITN usage by parturient include 
sweating inside the nets. These authors stated that sleeping and waking up time by 
parturients are associated with malaria parasitemia. The use of ITN during pregnancy is 
associated with maternal malaria parasitemia compared to non ITN users.  
Dionne-Odom et al. (2017) stated that the factors associated with ITN usage among 
owners include age, higher education, and wealth level (maternal and paternal), use of 
family planning, having children under 5 years in the home, and the non-usage has an 
association with polygamy.  
 Ezire et al. (2015) reported from their study in Nigeria that there is high 
knowledge and intention to use the ITN with 64.6% population having ITN while only 
19.2% sleep under the ITN. The authors stated that the knowledge of the risk of malaria 
and the benefits of using the ITN does not translate into the use of the ITN by parturients. 
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Anikwe et al. (2020) also reported that the use of ITN in Nigeria is far below the 
recommended standard. 
Resistance of Malaria Parasite to IPTp-SP, IRS, and ITN 
 Toure et al. (2019) in their study on predictors of malaria infection in pregnancy 
in Guinea, reported that maternal resistance to anti-malaria drugs was a predictive factor 
for both peripheral and placenta parasitemia. They found that rural dwellers are at 
increased risk of malaria compared to urban dwellers. Odonga et al. (2016) in their 
investigation on the impact of placental malaria infection on pregnancy outcome, 
compared IPTp-SP two-dose compliance pregnant women with the non-compliance ones 
and reported that there was no difference in birth weight between IPTp-SP two-dose 
compliance as compared to the non-compliance. The above observation could be 
attributed to parasite resistance to anti-malarial drugs or inadequate doses of the IPTp-SP 
medicine by parturient or impact of other risk factors of MiP.  
Several authors, (Ngondi et al., 2017; Odonga et al., 2016; Ruizendaal et al., 2017) 
reported the frequency of molecular markers of IPTp-SP resistance in malaria parasites. 
Ngondi et al. (2017) showed in their study in Tanzania, that the dihydropteroate 
synthetase (dhps) 581 parasite gene was common at one health facility but infrequent in 
all the others, signifying that there is geographic micro-heterogeneity in mutant 
distribution. These authors suggested that more studies at various locations are required 
to understand the effect of the dhps 581 mutant on the continued suitability of IPTp-SP. 
Therefore, proper surveillance involves the addition of many locations.  
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 The study by Ruizendaal et al. (2017) was able to ascertain the prevalence of 
IPTp-SP resistance mutation of P. falciparum in pregnant women and the public from 
Nanoro, Burkina Faso. These authors determined the relationship of IPTp-SP dosing with 
mutations. The result revealed that the occurrence of the triple dihydrofolate reductase 
(dhfr) gene mutation was high and significantly higher among the public and during 
delivery than at ANC enrollment. The quintuple mutations (high resistance strain) were 
established for the first time in Burkina Faso in that same study. Although IPTp-SP did 
not significantly affect the occurrence of any of the variations, a high transmission season 
was linked with increased mutation frequency in delivery samples. The results of these 
studies raised concerns about the efficacy and continued use of IPTp-SP subsequently.  
 A study by Achu et al. (2020) revealed the existence of various mutant strains in 
their study location, indicating IPTp- SP resistance progression. These authors reiterated 
that the subsequent appearance of mutation at various codons is expected, which will 
compromise the sustained effectiveness of IPTp-SP in the study area. Further, they 
suggested that routine surveillance and epidemiological monitoring of mutant strains and 
IPTp-SP efficacy is necessary for appropriate interventions. Also, additional studies are 
required to determine the reason for the variability in the outcome from PCR and 
restriction fragment length polymorphism (RFLP) in parasite detection in their study. 
Consequently, research on existing malarial parasite resistant strains, and drug 
combinations to address MiP was recommended.  
 Based on the current knowledge, there is a need for expanded epidemiological 
and surveillance studies in various locations to determine the association between 
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asymptomatic placental malaria infection with pregnancy outcome, including the 
univariate analysis of potential risk factors, which could support tailored and result-
oriented interventions. 
  The WHO (2017) recommended that regions with reports of Plasmodium 
falciparum histidine-rich protein 2 and 3 amino acid (pfhrp2/3) deletions should carry out 
extrapolative reference investigations among malaria cases to access the prevalence 
of pfhrp2/3 deletions that are triggering false-negative RDT results, to determine if the 
existing threshold for RDT (>5%) pfhrp2 deletions causing false-negative RDT results) is 
due for change (De Beaudrap et al., 2016). 
  Rogerson et al. (2018) stated that RDT malaria testing techniques are low in 
detecting the parasite in pregnancy while the PCR is useful in detecting low parasite 
density. These authors reported that the ongoing clinical vaccine trial is based on variant 
surface antigen 2-chondroitin sulphate A (VAR2CSA) and suggested that sequence 
variation be further explored to ensure a successful outcome. The authors suggested that 
comprehensive studies with pregnant women to monitor the trend and pattern of 
transmission across various geographical zones are required.  
 In their multicenter study, Bardaji et al. (2016) showed that the molecular 
diagnostic method was more sensitive in revealing submicroscopic infection than 
microscopy, and Achu et al. (2020) corroborated this outcome. Bardaji et al. (2016) 
concluded that P. vivax was associated with anemia, impacting fetal health significantly 




 Reports by researchers finding that the primigravidae (first pregnancy) are highly 
susceptible to malaria infection compared to the secundigravidae and multigravida 
(second and subsequent pregnancies) (Omer et al., 2017) remains controversial based on 
the evidence in the consulted literature (Anorue et al., 2020); still, Olukosi and Afolabi 
(2018) stated that malaria infection was detected more in the third trimester of subjects 
and primigravida. A study in Asaba, Delta State by Achu et al. (2020) was longitudinal, 
monitoring the effect of IPTp-SP on P. falciparum mutant strain using peripheral blood. 
These authors stated that the primigravidae showed a higher prevalence of malaria 
parasite compared to the multigravida. Anorue et al. (2020) reported that the multigravida 
(women who have been pregnant more than twice) were more impacted by placental 
malaria compared to the primigravidae (women in their first pregnancy) and 
secundigravidae (women in their second pregnancy). Moreover, Dogara et al. (2017) 
noted that the multigravida had a higher prevalence than the secundigravidae and 
primigravidae in Dutse, Jigawa State, Nigeria.  
 Based on the reviewed articles, there is a gap in the current knowledge on risk 
factors of MiP, and further study is required at various locations. The risk factors seem to 
be region/location specific. The inconsistent trends warrant additional investigation to 
understand the risk factors responsible for MiP in this study location. The suggestions in 
the cited materials indicate an ongoing real-world threat of malaria and the resistance of 
the Plasmodium parasite to anti-malaria medicine among pregnant women. The identified 
problem is meaningful, and further study is needed. Identifying the association between 
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asymptomatic PMPM, IPTp-SP compliance, the use of CAM and pregnancy outcome in 
this study could enhance the previous efforts in managing and controlling malaria 
infection in pregnancy in the study location and beyond (Feleke et al., 2020; Rogerson et 
al., 2018).  Additionally, the systematic review study by Kakuru et al. (2019) on the 
assessment of available evidence on the influence of P. falciparum and IPTp-SP during 
pregnancy and subsequent life of the babies reported that the reviewed documents 
showed heterogeneous results. The authors suggested that further studies are required on 
the subjects (parturient) to confirm malaria in pregnancy and the impact of IPTp-SP 
while adjusting for malaria transmission intensity. 
Summary and Conclusions 
 The global campaign for malaria elimination and eradication has not yielded 
expected outcomes due to vector resistance to insecticides, parasites resistance to anti-
malaria medicine, including economic, and administrative issues (WHO, 2020). The 
WHO, the CDC and several researchers stated that malaria is both preventable and 
treatable despite the nagging hindrances in achieving elimination. Some countries have 
achieved eradication (Argentina, Paraguay, Sri Lanka, and Uzbekistan). In contrast, 
others have achieved elimination (Azerbaijan, Costa Rica, and Turkey) and are in the 
process of eradication via the use of existing interventions despite their limitations. It 
implies that the existing interventions/tools are sufficient to eliminate and eradicate 
malaria (Shretta et al., 2017).  
 The findings from the reviewed research are largely inconclusive, creating a gap 
for the further investigation determined in this study. The existing studies did not 
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determine an association between PMPM, IPTp-SP compliance, the use of CAM and 
pregnancy outcome across various healthcare facility levels. Besides, the univariate and 
bivariate analysis of ITN ownership, ITN frequent use, gravidae, ANC attendance, age 
group, and education attainment of subjects were accessed to determine the prevailing 
risk factors in Asaba, Delta State, southern Nigeria.  
 Moreover, current reports revealed that malaria predictors and risk factors vary 
across various regions in SSA, and the sensitivity of the current malaria testing 
techniques is a vital concern in the elimination and eradication plan (Omer et al., 2017; 
Rogerson et al., 2018). The widespread variability/geographical specificity of study 
outcome on malaria in pregnancy warrants epidemiological studies in various locations to 
ascertain the continued usefulness and utilization of the existing interventions (e.g., IRS, 
ITN, IPTp-SP, and case managements) which are region/location specific. 
I observed from the reviewed studies that various researchers from other location used 
cross-sectional study designs with the quantitative method and hospital data to investigate 
MiP and the findings were a useful contribution to existing knowledge with positive 
social change (Achu et al., 2020; Anchang et al., 2020; Anorue et al., 2020; Omer et al., 
2017; Rogerson et al., 2018; Quakyi et al., 2019). 
In this chapter, a discussion of the current evidence on MiP was presented, while the next 
chapter highlighted the methodology, a description of the study population, sample size 




Chapter 3: Research Method 
Research Design and Rationale 
 I structured this cross-sectional study design with a quantitative methodology to 
determine the association between PMPM, IPTp-SP compliance, the use of CAM, and 
pregnancy outcome among asymptomatic pregnant women in Asaba, Delta State, 
Nigeria.  A univariates analysis of subject’s ITN ownership and ITN frequent use, ANC 
attendance, gravidae, age groups, educational attainment, and PMPM was investigated.  
I selected Primary, secondary, and private healthcare facilities randomly from the 
existing healthcare facilities in Asaba, the capital of Delta State for this study. A cross-
sectional study is an observational study that involves the analysis of data collected from 
a population, or a representative subset, at one specific point in time. Cross-sectional 
studies are useful for testing hypotheses, establishing the odds ratio, and relative risk for 
developing a disease based on someone’s exposure status to a risk factor (Szklo & Nieto, 
2019). Cross-sectional studies are ideal because it involves a large sample size, and many 
risk factors/covariates can be tested simultaneously. Cross-sectional studies are cost and 
time-efficient compared to case-control and cohort studies (Creswell & Creswell, 2018), 
and it  reveals the trend, pattern, and prevalence of the exposure and outcome variables. 
However, cross-sectional studies are limited with respects to the temporal association 
between exposure and outcome because it is void of the time elements (data collection is 
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limited to a single point in time (single dimension; Creswell & Creswell, 2018; Rudestam 
& Newton, 2014).  
 A study by Omer et al. (2017) was a hospital-based study involving parturients 
presenting for delivery. The authors ascertained PMPM in association with pregnancy 
outcome in Blue Nile State, Sudan. The highlighted risk factors from the study were 
maternal young age, primigravidae, secundigravidae, non-registration at ANC, non-usage 
of ITN, and maternal anemia. These authors stated that there is no association between 
education and residential location of parturients with placental malaria. They concluded 
that there was a high prevalence of placental malaria in the study area were due to the 
non-utilization of malaria interventions. These authors reported adverse pregnancy 
outcomes with respect to maternal anemia and LBW. In addition, Kang et al. (2016), in a 
study used retrospective hospital data for the analysis of malaria cases in Malawi. The 
authors stated that hospital data were sufficient for the observed trend for gender and age. 
Ozofor and Onos (2017) in their study used retrospective hospital data on malaria cases 
for 6 years. The enumerated studies yielded valid results to the clinical studies. 
The research questions for this study are restated below: 
 RQ1: What is the association between PMPM (independent variable 1 [IV1]), 
IPTp-SP compliance (independent variable 2 [IV2]), the use of CAM (independent 
variable 3 [IV3]), and maternal anemia (dependent variable [DV]) among pregnant 
women in Asaba, Delta State, Nigeria.? 
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H01: There is no association between PMPM (IV1), IPTp-SP compliance (IV2), 
the use of CAM (IV3), and maternal anemia (DV) among pregnant women in Asaba, 
Delta State, Nigeria. 
H11: There is an association between PMPM (IV1), IPTp-SP compliance (IV2), 
the use of CAM (IV3), and maternal anemia (DV) among pregnant women in Asaba, 
Delta State, Nigeria. 
RQ2: What is the association between PMPM (IV1), IPTp-SP compliance (IV2), 
the use of CAM (IV3), and baby’s birth weight (DV) among pregnant women in Asaba, 
Delta State, Nigeria? 
H02 There is no association between PMPM (IV1), IPTp-SP compliance (IV2), the 
use of CAM (IV3), and baby’s birth weight (DV) among pregnant women in Asaba, Delta 
State, Nigeria. 
H12: There is an association between PMPM (IV1), IPTp-SP compliance (IV2), 
the use of CAM (IV3), and baby’s birth weight (DV) among pregnant women in Asaba, 
Delta State, Nigeria. 
RQ3: What is the association between PMPM (IV1), IPTp-SP compliance (IV2), 
the use of CAM (IV3), and delivery term (DV) among pregnant women in Asaba, Delta 
State, Nigeria? 
H03 There is no association between PMPM (IV1), IPTp-SP compliance (IV2), the 




H13: There is an association between PMPM (IV1), IPTp-SP compliance (IV2), 
the use of CAM (IV3), and delivery term (DV) among pregnant women in Asaba, Delta 
State, Nigeria. 
 The variables in this study were collected from parturients in the last trimester 
during the ANC and when presenting for delivery, who met the inclusion criteria and 
consented. The outcome (maternal anemia, baby’s birth weight, and delivery term), 
predictors (PMPM, IPTp-SP compliance, the use of CAM), and other risk variables for 
univariates analysis (ITN ownership, ITN frequent use, ANC attendance, gravidae, age 
group, and educational attainment) were obtained via a survey questionnaire and 
validated with the hospital data. I distributed the consent form to subjects in their last 
trimester during the ANC and I also collected the consent form from consented 
parturients during their subsequent ANC visit and gave them the questionnaire to fill. I 
administered the questionnaires to consented subjects who cannot read at a safe distance 
void of overhearing by others.  
The study took place consecutively at the four randomly selected healthcare 
facilities with high ANC statistics. It is necessary to obtain these variables by survey 
because some (ITN ownership, ITN frequent use and use of CAM) are not routine ANC 
hospital data. Further, the malaria parasitemia (peripheral) is only determined for sick 
parturients by the healthcare facilities in Delta State. The asymptomatic subjects are not 
tested. Therefore, the comprehensive collection of these variables by coded structured 
questionnaire (survey) via collaboration with the partner organization will maintain 
ethical concern of subject’s privacy. However, the hospital case file number of subjects 
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were inscribed on the questionnaire of consented subjects for validation with hospital 
records. I secured the collected questionnaires in a locked drawer with limited access in 
my home during the data collection process to ensure confidentiality. The use of pretested 
structured questionnaire for data collection including validation with hospital records 
makes this study unique unlike other studies documented in current literature in the study 
location, Asaba, Delta State, southern, Nigeria and other areas.  
 The purpose of this study was to investigate the association between PMPM,  
IPTp-SP compliance, the use of CAM and pregnancy outcome (maternal anemia, baby’s 
birth weight, and delivery term) among asymptomatic pregnant women attending ANC 
and presenting for delivery. I utilized quantitative methodology in a cross-sectional study 
design with deidentified survey questionnaires and secondary routine hospital data 
collected from four healthcare facilities in Asaba, Delta State, Nigeria for this study. The 
subject’s ITN ownership, ITN frequent use, ANC attendance, gravidae, age groups, and 
educational attainment were also determined in a univariate and bivariate analysis among 
asymptomatic pregnant women in Asaba, Delta State, Nigeria. Therefore, my aim in this 
study was to extend research in the field by generating evidence on the disease burden 
and the significant risk factors of PMPM among asymptomatic pregnant women in the 
target population. 
 In this chapter, I have described the research design and rationale. The research 
questions and hypotheses were restated in this chapter, and it was followed by the 
description of the study variables. The methodology that I presented in this study 
included discussion about the target population, detailed procedure for data collection and 
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validation, subject recruitment strategies, sampling, and sample size calculation with the 
G*Power3 software including the use of Slovin’s formula (used to calculate sample size 
necessary to achieve a certain confidence interval when sampling a population with 
limited information about the population ‘s behavior). However, a larger sample size than 
was obtained from the sample size calculated from the Gpower3 software and the Slovin 
sample size formular because the larger the sample size, the more confident a researcher 
can be that the outcome/result of the study reflects the population. Large sample size 
implies smaller confidence interval (Cochran, 1977; Frankfort-Nachmias & Nachmias, 
2008). I explained the data collection instrument used in this study (the survey 
questionnaire as primary data and routine hospital data as secondary). Furthermore, I 
discussed the threat to validity and reliability, including how to mitigate them. In the 
instrumentation and operationalizing of the constructs section, I discussed how the 
instrument (survey questionnaire) was developed, the evidence, and possible threats to 
internal and external validity. I concluded this chapter with a detailed discussion of the 
ethical concerns and the informed consent protocols in the study. 
Methodology  
Study Population and Location 
 Delta State is an oil, commerce, and agriculturally relevant State in Nigeria. It is 
in the south-south geopolitical zone with a human population of 4,112,445 (males: 
2,069,309; females: 2,043,136) and according to the National Population Commission & 
National Bureau of Statistics. (n. d), it was projected to 5,663,362 (males: 2,888,315, 
females: 2,775,047) in 2016. Asaba is the capital city and is in the northern part of Delta 
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State. Delta State covers a landmass of 18,000 km (6,970 square miles), with about 60% 
land. It is bounded in the north and west by Edo States and in the east by Anambra, Imo, 
and River States, while on the southern part is the Bight of Benin encompassing 160km 
coastline. Delta State is low lying and void of hills (National Population Commission & 
National Bureau of Statistics, n. d). 
Study City/Area (Asaba) 
 The study sites for this research were four healthcare centers (primary, secondary, 
and private healthcare facilities) in Asaba. Asaba is the administrative capital of Delta 
State and is composed of people of different cultural and socioeconomic backgrounds 
from within and outside Nigeria. It is located at the northern end of the state and has an 
estimated population of 150,032 (2006 census) and is projected to 181,571 in 2012 at a 
growth rate of 3% (National Population Commission, n. d). It has an estimated area of 
762 square kilometers. The city of Asaba is located at the western edge of the River 
Niger. The Niger Bridge links Asaba to Onitsha in Anambra State. Asaba maintains an 
average tropical temperature of 32°C during the dry season and an average rainfall of 
2,700 mm during the rainy season, and the city falls within the tropical rain forest region 
of Nigeria with two major seasons: rainy and dry, with intermittent of harmattan weather. 
The people are engaged in farming, fishing, commerce, industry, and public and civil 
service jobs. The sandy beaches of the river are good sites and grounds for recreation and 
tourism. Travelers from other neighboring States and Regions are attracted to the city, 
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which is an essential factor in the transmission of infectious diseases including malaria 
(City Population, n. d) 
 The language of the indigenous Asaba people is the Ibo language, but its function 
as the state capital attracted a multitribal population with diverse languages such as 
Urhobo, Itsekiri, Isoko, Ijaw, Hausa, Yoruba, Fulani, and other minority tribes. Hence the 
general/common language is the low-grade English language popularly known as Delta 
pidgin English (Wikipedia, 2020). The Google Map showing Asaba, Delta State is 
presented as Figure 3. 
Figure 3. 






Sampling Approaches (Sample Size and Power Calculation) 
 Power analysis is used to determine the suitable sample size required to detect an 
anticipated effect (small, medium, or large) for a study. The effect size measures the 
strength of the relationship/association between variables, which gives information on the 
practical meaningfulness of the relationship among variables (Maher et al. 2013). 
Conducting a power analysis prior to a research study enhances the probability of 
obtaining a valid, reliable, and accurate statistically significant result (Rudestam & 
Newton, 2014). I determined the sample size using the G*Power3 software to calculate 
the minimum sample size based on a medium effect size of 0.3, α of 0.05, power of 0.80 
and degree of freedom (df) of five (the df is a function of the number of column and rows 
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of the DVs and IVs). The output gave a total sample size of 143 for the study as shown in 
the figure 4 from the G*Power3 software output below.  
Figure 4 
 
Output of the G*Power3 Software Calculation for the Sample Size for This Study 
 
 
The Target Population and Sample Size 
 The Slovin formula (used to calculate sample size necessary to achieve a certain 
confidence interval when sampling a population with limited information about the 
population‘s behavior) was used to determine the required sample size as well. The 
Slovin formular gives researchers the desired accuracy when working with a population 
that is too large to be sampled in a study (Cochran, 1977). The target population for this 
study was made up of parturients between the ages of 18–49 years, and who reside in 
Asaba, Oshimili South local government area, Delta State, Nigeria. The estimated female 
population in Asaba, Oshimili South local government for 2020 was projected at a 3% 
growth rate as 110,171 of which 26,441 were females of reproductive age (24% of female 
population) and the population of parturients was 1,322 (5% of reproductive-age women; 
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National Population Commission, n. d). The figures above were used with a margin error 
value of 0.05 and N as 1,322 (with Slovin’s formula: n = N/ (1+[N{e}2]) to arrive at an 
adequate sample size for this study of 307. So, adjusting for a 10% response rate gave a 
sample size of 338.  
The Study Duration, Inclusion, and Exclusion Criteria 
 The study duration: The data collection period was  10 weeks from May 6 to July 
7, 2021.  
The inclusion criteria: The inclusion criteria  involved asymptomatic pregnant 
women attending ANC and presenting for delivery in the four randomly selected 
healthcare facilities for the study. Every patient that qualifies as a subject, and who has 
consented to participate in the study with an auxiliary temperature of ≤ 37.5oC, absence 
of fever, chills, and headache in the last 24 hours were recruited for this study. 
The exclusion criteria: The exclusion criteria were that any pregnant woman who 
does not want to participate, or did not sign the informed consent, ill or admitted to the 
intensive care unit or nonpregnant women and parturient does not reside in the study 
area. Parturients younger than 18 years or older than 49 years were not recruited. 
The Recruitment and Data Collection Approaches 
The Recruitment of Subjects 
 The knowledge and clarification of the study was relayed to the healthcare staff at 
the ANC, labor ward, and laboratory units of the four randomly selected healthcare 
facilities in a focused health group discussion by me. The focused group discussion 
helped to inform and train the hospital staff (partner organization) of this study. The 
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awareness and training are necessary due to the collaboration in the data collection. The 
data was collected as primary (survey questionnaires) and secondary (hospital record) 
data. The primary data included the use of CAM, educational attainments, employment 
status, ethnicity, residential location, age, phone ownership, usage, internet access, ANC 
attendance, parity, gravidae, ITN ownership, ITN frequent use, IPTp-SP compliance, and 
the secondary variables are placental malaria parasitemia (PMP) by RDT and 
microscopy, maternal anemia, baby’s birth weight, delivery term, maternal, and neonatal 
outcome. 
The Data Collection 
 This study instrument was a survey questionnaire with validation using the 
hospital records. The creation of the questionnaire was guided by the NMIS questionnaire 
pattern as most of the survey questions were framed/patterned after the NMIS questions 
which have already been validated and standardized (NMEP; NPopC), National Bureau 
of Statistics [NBS], and ICF International, 2016). The information from current literature 
and discussions with knowledgeable researchers (my committee) on MiP and clinical 
research guided me in developing the questionnaire instrument.  
The questionnaire was worded in a low-grade English language to enhance subjects’ 
understanding irrespective of their SES and educational attainments. The use of low-
grade English language to word the questionnaire was necessary because the ANC 
subjects have mixed socioeconomic status and educational attainments. The consistency 
of the questionnaire was maintained via a pretesting/pilot testing on 20 subjects, who 
were in their third trimester and attending ANC in a different healthcare facility (not 
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selected for this study) in the study location (Asaba). I distributed the consent and 
subsequently the survey to qualified (based on inclusion and exclusion criteria) and 
consented subjects.  
 The details of the pregnancy outcome variable were validated via the hospital 
records because most of the required data are part of the healthcare routine data. At the 
same time, the variables that were not contained in the hospital records (ITN frequent 
use, and the use of CAM variables) were not validated; however, the questions were in 
low grade English Language and the subjects were assured that their responses will not 
be used against them now or in the future. The questionnaire was then used to collect 
information from the subjects on residential location, gravidae, age, educational 
attainments, ITN ownership, ITN frequent use, and use of CAM.  
  While at delivery, a laboratory test for PMP by RDT and microscopy was carried 
out by the health facility laboratory scientists for all qualified and consented subjects as 
part of their routine care at no costs to the subjects. Each subject laboratory specimen was 
labelled with their assigned unique code/ID and hospital case file number on the subject’s 
questionnaire. The laboratory analysis was validated by a second senior 
technician/parasitologist, the outcome of the laboratory test was recorded in the subject’s 
hospital file and the test outcome was communicated to the subjects by the hospital 
management. The positive cases for malaria were treated with artesunate SP, while 
positive anemic cases were treated with folic acid and iron supplements according to 
WHO standards at no cost to the subjects by the healthcare facility. The data were 
validated, de-identified, and information linking the data to the subjects (hospital case file 
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numbers) was removed permanently before the data was analyzed and subsequently 
published. 
The PMP Via Microscopy 
 Placental blood (2mL) was collected (within one hour of delivery) from the 
maternal side intervillous space of the placenta using a sterile disposable lancet and 
stored in an Ethylene Diamine Tetracetic Acid (EDTA) anticoagulant bottle labelled with 
the subject’s code/ID (hospital file number) and sent to the laboratory. Blood smears 
were prepared on a grease-free, clean glass slide at 15mm apart on both ends of the glass 
slide for the thick and thin smears on the same glass slides with a spreader slide and 
allowed to air dry before staining with 10% Giemsa at pH 7.2 for 10 minutes and 
examined under the ×100 oil immersion objective lens of a light microscope 
(Chessbrough, 2006). High-power magnifications were used to detect the presence of 
parasites on thick film, while thin films were used to determine the parasite species from 
positive thick films. The staining and blood film examination was based on the WHO 
guidelines (WHO, 2010). Also, the parasite density was ascertained with the plus system 
(Cheesbrough, 2006), which involves the counting of parasites number per high power 
field and evaluated according (+ [1–10 parasites per 100 high power fields], ++ [>10 
parasites per 100 high power fields], +++ [1–10 parasites in one high power field], and 
++++ [>10 parasites in one high power field]). If no parasites were observed in 100 
fields, the sample was considered negative. The Plasmodium species attributes were used 
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to identify the species of Plasmodium encountered (Chessbrough, 2006; WHO, 2010; 
WHO, 2015). 
The PMP Via RDT Testing 
 The malaria P. falciparum test cassette was detached from the foil pouch and 
placed on a dry surface. Each test cassette was labeled with the subject’s code/ID 
number. A drop of the blood sample was placed on the test cassette, and three drops of 
diluents added immediately and allowed to run for 10 minutes. The presence of a purple 
color band in the result window of the test cassette guides the result interpretation. The 
purple color band on the test reaction zone and the control reaction zone in the result 
window means the sample was positive whereas a purple color band on the control 
reaction zone in the result window was interpreted as a negative result (WHO, 2010; 
WHO, 2020).   
The Laboratory Determination of Maternal Anemia 
The packed cell volume (PCV) analysis was used for the determination of 
hemoglobin level. Venous blood samples were used to determine hemoglobin level of the 
subjects. Capillary tube labelled for each subject code was filled with blood to about two-
third of the length of the tube, and one end of the tube was sealed with plasticine. This 
was centrifuged with hematocrit centrifuge at 5000 revolutions per minute for five 
minutes. The packed cell volume of the sample was read with a standard Hawksley 
micro-hematocrit reader. The maternal anemia based on the standard hematocrit reader 
value of 11 g/dL as normal, 10 g/dL to 10.9 g/dL as mild, 7 g/dL to 9.9 g/dL as moderate, 
and less than 7 g/dL as severe anemia (WHO, 2011). These values were recoded as 
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anemia absent (AA) and anemia present (AP). The normal value determined at the third 
trimester were recoded as AA and the mild, moderate, and severe anemia as (AP).  
Data analysis (logistic regression). 
 The data was analyzed using the SPSS version 25. The data was sorted and 
checked before computer data entry. The outcome and predictor variables were binary 
and categorical variables. I produced an initial descriptive statistic in tables and charts 
with percentages to describe the frequency distribution of the sociodemographic 
variables/characteristics of the independent variables. Descriptive statistics were carried 
out to explain the study population in relation to relevant variables. A Chi-square test was 
performed to ascertain the association between PMPM and each of the selected risk 
variables (ITN ownership, ITN frequent use, ANC attendance, gravidae, Age groups and 
educational attainment). The Chi-square assumption were accessed for all categorical 
independent variables and multicollinearity using the variance inflation factor (VIF) or 
correlation estimates. The model goodness of fit was determined using the Hosmer-
Lemeshow test. The inferential statistics includes binomial logistic regression analysis to 
investigate the association between PMPM, IPTp-SP, CAM, and each of the DVs at a P-
value of ≤ 0.05. The RQ 1, RQ 2, and RQ 3 were analyzed by binomial logistic 
regression. A univariate analysis was done to explain the study population in relation to 
selected risk variables. The P-value determined at 0.05 was the basis for the acceptance 
or rejection of the null hypothesis. (Frankfort –Nachmias & Nachmias, 2008). The use of 
binomial logistics regression and Chi-square test aligned with the research question and 
the restrictive assumptions of linear regression were not required in logistic regression. It 
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was a robust statistical analysis (Creswell & Creswell, 2018; Rudestam & Newton, 
2014). Binomial logistic test is suitable because it could ascertain the level and 
significance of the variables (Forthofer, & Lee, 2014; Kanyangarara et al., 2016; 
Sichande et al., 2014). Besides, the study outcome and predictor variables were binary 
and dichotomous. (Hidalgo & Goodman, 2013). The Chi-square analysis was selected 
because of its popular application in finding the association between a categorical or 
dichotomous dependent and independent variables (Creswell & Creswell, 2018; 
Rudestam & Newton, 2014).  
Instrumentation and Operationalization of Construct (Instruments to Measure 
The Questionnaire 
 The questionnaire was partitioned with the same sequence of items for each 
participant. I avoided paraphrasing/rewording the questions or providing expressive 
information, interpretation, or explanations to the subjects. The aim was to ensure that the 
differences in response to questions were due to real difference among subjects. 
(Frankfort-Nachmias & Nachmias, 2015; Rudestam & Newton, 2014). The subjects were 
assigned specific code/ID number (for identification) which were used to match all data 
collected. Information on all the variables were recorded in the questionnaire. This study 
questionnaire is attached as Appendix A. 
Evidence for Reliability and Validity of Instruments 
 Reliability refers to the function of a test to produce a consistent/same result, 
when used to measure the same thing, at different times, while validity measures what it 
proposes to measure. The use of probability sampling and sampling formula in this study 
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ensured standardized effect size and representativeness. Besides, the questionnaire items 
were carefully worded to avoid misleading, intimidating, or double-barred questions 
(Frankfort–Nachmias & Nachmias, 2015; Rudestam & Newton, 2014). Moreover, the 
pilot test and adjustment of the questionnaire based on the outcome enhanced the 
reliability and validity of the study.  
Mitigating Threat to Internal and External Validity 
 The chosen design of the study incorporated some methodological strengths, 
however, some threats to validity exist in this study. The self-reported nature of some 
variables may have introduced recall bias, which may lead to inaccurate data provided by 
the participants. Social desirability may have affected the accuracy of reporting of the 
sociodemographic, SES, ITN frequent use, and use of CAM especially due to the lack of 
anonymity in the data collection approach. However, the subjects were informed in the 
consent form that the information they gave will not be used against them now or later 
and nobody will refer to it against them personally.  
 The study is a cross-sectional design, and the findings can only be extrapolated in 
the context of time to the setting of the survey, and a population with similar features. 
The external validity could be threatened if any inference is made, or findings 
extrapolated to other population/settings/past/future situations (Creswell & Creswell, 
2008). Other possible sources of threat to the internal validity of the study could be 
through the processes of sample selection, data collection, and instrumentation (Creswell 
& Creswell, 2008). Also, the random sampling in health facility selection could prevent 
possible threat to internal validity. The selection of participants with likely extreme score 
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could also be a threat to internal validity (Creswell & Creswell, 2008). Possible threats to 
construct validity could be due to inadequate or wrong definitions and measurement of 
research variables (Creswell & Creswell, 2008). The independent variables and other risk 
variables were explained based on the SEM (Champion & Skinner, 2008). Chi-square, 
and binomial logistic regression were properly applied, to avoid threat to construct 
validity. 
The Measurement of Variables 
The required hospital data (variables) include the following outcome, predictors, and risk 
variables for univariate analysis:  
• Pregnancy outcome variables (dependent/outcome variable; DV) including 
maternal anemia based on the standard hematocrit reader categorized as mild, 
moderate, and severe anemia. The maternal anemia based on the standard 
hematocrit reader include 11 g/dL as normal,10 g/dL to 10.9 g/dL as mild, 7 g/dL 
to 9.9 g/dL as moderate, and less than 7 g/dL as severe anemia (WHO, 2011). 
These values were recoded as anemia absent (AA) and anemia present (AP).The 
normal anemia value at delivery were recoded as AA and the mild, moderate, and 
severe anemia as AP. It was recoded as anemia absent (AA) and anemia present 
(AA); baby’s birth weight, above or equals 2.5 kg as normal birth weight (NBW), 
and below 2.5 kg as low birth weight (LBW), preterm and term delivery as less 
than or equal to 36 weeks and equal to or greater than 37 weeks, respectively.  
• Predictor variables; The independent/exposure variables (IVs) including maternal 
placental malaria parasitemia (IV1) as positive (presence) placental malaria 
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parasitemia (PPMP) and negative (absence) placental malaria parasitemia 
(NPMP); the IPTp-SP (IV2) as to compliant to three or more doses of IPTp-SP 
during pregnancy (adequate) and not compliant as none or less than three doses 
IPTp-SP during pregnancy (inadequate) and use of CAM (IV3) as Yes, No 
responses.  
• Other variables for univariates analysis include the subject’s ITN ownership (Yes, 
No), ITN frequent use (Yes, No), ANC attendance, gravidae (primigravidae, 
secundigravidae, and multigravida), age groups, and educational attainment 
(none, primary, secondary, tertiary and, above). Table 1, showing the 






The Variables, Response Code and Measurement Type used in This Study 
 
Variable Response Code Measurement 
Dependent/outcome 
Maternal anemia Dichotomous/Nominal 
AA 0  
AP 1  
Baby’s birth weight Dichotomous/Nominal 
NBW 0  
LBW 1  
Delivery term Dichotomous/Nominal 
TD 0  
Preterm 1  
Independent/Predictor 
PMPRDT Dichotomous/Nominal 
NPMPRDT  0  
PPMPRDT 1  
PMPM Dichotomous/Nominal 
NPMPM 0  
PPMPM 1  
IPTp-SP compliance Dichotomous/Nominal 
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Adequate  0  
Inadequate 1  
CAM Dichotomous/Nominal 
No 0  
Yes 1  
Risk variables 
ITNs ownership Dichotomous/Nominal 
No 0  
Yes 1  
ITNs use Dichotomous/Nominal 
No 0  
Yes 1  
Gravidae Ordinal/Nominal 
Primigravidae 1  
Secundigravidae 2  
Multigravida 3  
 Age group (years). Ordinal/Nominal 
18–25 1  
26–34 2  
35–42 3  
43–49 4  
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Educational attainment Ordinal/Nominal 
None 0  
Primary 1  
Secondary 2  
Tertiary 3  
 
Ethical Consideration 
 Approval from the institutional review board (IRB) from Walden University, the 
Delta State Ministry of Health, the data sites, and the subject’s confidentiality 
requirement were maintained as only the de-identified data were analyzed and published. 
The validation of some variables with the hospital file were done by me. Moreover, this 
study is void of exploitation of subjects because the outcome of the study for maternal 
malaria and anemia at the individual level were explained in simple terms to the hospital 
management to relay to their patients. The positive malaria parasitemia cases were 
informed and treated with artesunate SP based on WHO guidelines and counselled to 
seek early malaria treatment for their neonates when unwell. Moreover, the healthcare 
system was advised to adjust their interventions and care to mitigate the adverse outcome 
of MiP on their patients based on the study outcome and recommendation. 
The consents form would indicate that a participant was at liberty to exit the study at any 
point during the study. The process to leave the study was simply by informing the 
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researcher. Any subject who wishes to withdraw from the study was not swayed, coaxed, 
or pressured to continue.  
Informed Consent 
 The subjects were given complete information about the study at individual 
levels. The formal consent in writing or thumb printed before the administration of the 
questionnaire were secured. I provided each subject with standardized introductory 
information about the study as contained in the questionnaire, after which the subjects 
were expected to either give or not give consent. The information, which was provided in 
the low-grade English language for the understanding of the subjects, included research 
purpose, the source of organizational and monetary support for the study, and the 
estimated duration (15 minutes) in filling the questionnaire. 
 After delivery of the baby and placenta, 2 mL of blood was taken from the 
placenta by the healthcare laboratory scientist for RDT and microscopy analysis to 
determine the maternal malaria parasitemia status. Also, the hospital record of subjects 
for maternal anemia test analysis was recorded in each subject’s questionnaire. As 
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detailed by Creswell and Creswell (2018) a consent form was developed and used to 
produce information on the following: 
• Explain the identity of the investigator and the supportive academic organization. 
• Guarantee of confidentiality concerning the subject’s information. 
• Explain the aim of the study. 
• Assess the level of subjects’ commitment. 
• Explain the advantages of the study to subjects. 
• Ask permission to contact each subject for follow-up questions by the researcher; 
and 
• Give the women the freedom to participate or withdraw from the study at any 
time, simply by informing the researcher. 
• Each participant either sign or thumbprint on the consent form as a mark of 
consent. 
Limitations, Challenges, and Barriers of the Study 
 This study was a cross-sectional design; therefore, causality cannot be 
ascertained, since all samples were taken at delivery. The impact of past infection on 
maternal, fetus, and neonatal outcomes cannot be determined. Also, the bias arising from 
self-reporting of demographic and socioeconomic status variables are envisaged in this 
study; consequently, the mitigation through validation with hospital records was 
appropriate. The information bias from self-reporting of survey data was mitigated by 
adequate training of the subjects before the data collection, pretesting of the 
questionnaire, and validation with hospital records and phone calls. Further, some factors 
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that could impact fetal outcome, such as maternal nutritional status, child spacing, genetic 
influences, other infectious diseases, smoking and wrong use of alcohol were not 
investigated in this study (Kapisi et al., 2017). 
Strength of the Study 
 An essential strength of the study was the use of binomial logistic regressions for 
the statistical analysis because it is robust in identifying confounders and it is less 
restrictive for assumptions (Feleke et al., 2020). Also, the use of a pretested structured 
questionnaire was to ensure appropriate baseline understanding of the survey questions. 
And lastly, the selection of four health care facilities (primary, secondary, and private 
health care facilities; comprising two public and two private healthcare facilities) in the 
state could afford better comparison of study outcomes based on the level of care and 
location. All the consulted study in Nigeria used data from a single healthcare facility in 
their study. 
Pilot Testing 
  The questionnaire was pilot tested among 20 respondents with same population 
features as the study population. The pretest was done in different healthcare facility that 
was not used for actual data collection. The aim of the pilot test was to ensure baseline 
understanding of the survey question by subjects during the actual data collection. The 
result of the pilot test was not reported in this study but was discussed with my committee 
and the required change(s) in the survey question (framing) was applied accordingly. 
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Summary and Transition 
 This cross-sectional quantitative research study used hospital based primary and 
secondary data from four healthcare facilities in Nigerian to determine the association 
and the risk factors for PMPM and pregnancy outcomes in the studied population. The 
data validation was with hospital records (secondary data). The predictor variables and 
outcome variables, as well as the selected risk factors variables, were discussed with their 
respective coding for statistical analyses. All statistical analyses were conducted with 
SPSS version 25, and I reported the details of the results and the analysis of the findings 
in Chapter 4. I presented the descriptive statistics of the study variables in tables. 
Specifically, the inferential statistics was carried out through binomial logistic regression 
models and the calculation of odds ratios, I tested the six null hypotheses in this study. 
Subsequently, I discussed the results of each of the three research questions and 




Chapter 4: Results. 
Introduction 
 In the previous chapter, I detailed the study methodology. I provided a summary 
of the purpose, a restatement of the research questions and hypotheses, description of the 
sampling procedures, and data collection process. I designed this study to investigate the 
association between asymptomatic malaria infection and pregnancy outcome among 
pregnant women using quantitative methodology with a cross-sectional design and the 
risk factors related to placental malaria were analyzed. The findings could provide a basis 
for a review of policies and interventions at policy, service delivery, and community 
levels to increase the uptake of the recommended measures/interventions for the 
prevention of MiP. I developed three RQs and three sets of hypotheses for this study, the 
RQs are as follows: 
 RQ1: What is the association between PMPM (independent variable 1 [IV1]), 
IPTp-SP compliance (independent variable 2 [IV2]), the use of CAM (independent 
variable 3 [IV3]), and maternal anemia (dependent variable [DV]) among pregnant 
women in Asaba, Delta State, Nigeria.? 
H01: There is no association between PMPM (IV1), IPTp-SP compliance (IV2), 
the use of CAM (IV3), and maternal anemia (DV) among pregnant women in Asaba, 
Delta State, Nigeria. 
H11: There is an association between PMPM (IV1), IPTp-SP compliance (IV2), 
the use of CAM (IV3), and maternal anemia (DV) among pregnant women in Asaba, 
Delta State, Nigeria. 
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RQ2: What is the association between PMPM (IV1), IPTp-SP compliance (IV2), 
the use of CAM (IV3), and baby’s birth weight (DV) among pregnant women in Asaba, 
Delta State, Nigeria? 
H02 There is no association between PMPM (IV1), IPTp-SP compliance (IV2), the 
use of CAM (IV3), and baby’s birth weight (DV) among pregnant women in Asaba, Delta 
State, Nigeria. 
H12: There is an association between PMPM (IV1), IPTp-SP compliance (IV2), 
the use of CAM (IV3), and baby’s birth weight (DV) among pregnant women in Asaba, 
Delta State, Nigeria. 
RQ3: What is the association between PMPM (IV1), IPTp-SP compliance (IV2), 
the use of CAM (IV3), and delivery term (DV) among pregnant women in Asaba, Delta 
State, Nigeria? 
H03 There is no association between PMPM (IV1), IPTp-SP compliance (IV2), the 
use of CAM (IV3), and delivery term (DV) among pregnant women in Asaba, Delta 
State, Nigeria. 
H13: There is an association between PMPM (IV1), IPTp-SP compliance (IV2), 
the use of CAM (IV3), and delivery term (DV) among pregnant women in Asaba, Delta 
State, Nigeria. 
 In this chapter, I provided a summary of the study purpose and research questions. 
In addition to the introduction, there were three sections in this chapter: data collection, 
results, and summary. The data collection discussed in chapter 4 described the data 
collection timeframe and a description of the sample. In the results section, I described 
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the data cleaning and coding process, provided the descriptive statistics of the 
demographic/sociodemographic data, placental malaria parasitemia and obstetrics data, 
the malaria intervention variables, and evaluates the statistical assumptions of the 
statistical tests performed to answer the research questions. The statistical analysis 
findings were organized by the research questions. The results of the univariate 
descriptive statistics, Chi-square (bivariate) statistical analysis of the enumerated risk 
factors (ITN ownership, ITN frequent use, ANC attendance, gravidae, age groups, and 
educational attainment), and the placental malaria parasitemia by microscopy (PMPM) 
variable were presented as well. Finally, in the chapter 4 summary, I gave a collation of 
the outcome of the analysis from the research questions and transitions to chapter 5. 
 The pilot test was done on May 5, 2021, on 20 subjects in another health care 
facility in Asaba that was not listed for the study. The focus of the pilot testing was to 
establish baseline understanding of the survey questions among the parturients. The result 
of the pilot test did not impact the data collection procedure. I stated in the proposal that 
the pilot study aimed to ensure baseline understanding of the questions by the subjects 
and that I will discuss the outcome with my committee. If needed, I will reframe the 
questionnaire questions to ensure that all the subjects understand the questions. However, 
it was discovered after the pilot testing that there was controversy in deciding on the 
Question 7 of section B in the questionnaire: What is your residential location? Is your 
area a rural or urban location? it was difficult to decide which area was rural/urban 
because the recruitment criteria stated that the subject resides in Asaba and Asaba is the 
capital city of the State. Hence, I removed the Question 7 of section B. The pilot study 
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did not impact this study as there was no change in the data collection, instrumentation, 
or analysis process. 
The data preparation process comprises of three phases viz: the data preparation phase, 
the preliminary analysis phase, and the primary analysis phase.  
Data Preparation 
 All the subjects who were enrolled in an ANC in the selected healthcare facilities 
that met the inclusion criteria and consented were recruited into the study. The laboratory 
and obstetrics data of each subject were matched with the hospital file number of subjects 
on the survey questionnaires, and I transcribed them into the survey questionnaires and 
subsequently, the data were carefully entered into the Excel spread sheet version 2013 
and checked for error and missing values and corrected via validation with the hospital 
records. A total of 496 data were collected from the 500 questionnaires that were 
distributed. But after sieving out missing and incomplete data, I had 483 data points fit 
for the analysis. Thereafter, the data were opened in SPSS version 25 software package 
for further analysis as stated in the methodology outlined in Chapter 3. 
Preliminary Analysis 
 In this phase, some of the variables were recoded as proposed, and new variables 
were computed such as with the PCV values, which were converted to the hemoglobin 
(Hb) values by dividing by three (Abbott Point of Care Inc., 2016; Koperska, 2018), and 
thereafter recoded as anemia absent (AA) meaning no anemia, and anemia present (AP) 
meaning the presence of mild, moderate, and severe anemia. The IPTp-SP compliance 
variable was recoded into 0 as adequate and 1 as inadequate from the four compliance 
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levels of zero, once, twice, and more than twice with the inadequate group comprising of 
the zero, once, and twice while the adequate group is made up of more than twice 
compliance. According to Aguzie, (2018), the WHO recommended four or more doses 
before delivery in the malaria high burden region. So, in the preliminary analysis phase, 
tests of parametric assumptions were performed to determine if there were violations of 
the logistic regression and Chi-square analysis and if so, what other alternative analyses 
should be conducted. 
Primary Analysis 
 In the primary analysis phase, I performed statistical tests that answered the 
research questions of the study. In this study, descriptive statistics performed on the 
variables revealed no data errors. However, I observed a few missing/incomplete 
variables which lead to the reduction of the total data from 496 to 483 (after sieving out 
the missing/incomplete variables). The response rate for this study was 99.2%. 
 The following is a list of codes and definitions used in this study:  
 
PMP   Placental malaria parasitemia 
PMPM Placental malaria parasitemia by microscopy 
RDT Rapid diagnostic test. 
PPMP  Positive placental malaria parasitemia 
NPMP Negative placental malaria parasitemia 
AA Anemia absent 
AP Anemia present 
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BW Birth weight 
NBW Normal birth weight. 
LBW  Low birth weight 
GAD Gestational age at delivery 
N Population 
M Mean 
MD Mean deviation 
SD Standard deviation 
CI Confidence interval 
R2 Negelkerke pseudo  
H-L Hosmer-Lemeshow test 
 
 I conducted preliminary analyses to evaluate the assumptions of the logistic 
regression. The assumptions of the logistic regression are linearity (for continuous 
variables), multicollinearity, and absence of high correlation among the IVs (Pallant, 
2016; Tabachnick & Fidell, 2012). There was no violation in the assumption of linearity 
because the IVs were all binary and categorical variables. The outcome of the correlation 
analysis among the IVs showed that there was no high correlation among the IVs as the 
values were below the threshold of plus/minus 0.70/0.80 as shown in Tables 2 and 3 
below. The result of the collinearity diagnostics in Table 4, showed that the VIF values 
are below the threshold of 10. They are less than five, which is best. This implies that the 
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IVs are not highly correlated with each other and there is no violation of the 
multicollinearity assumption as well. 
Table 2. 
 













1.000 0.042 0.015 -0.055 0.031 
P-value - 0.362 0.744 0.228 0.491 
N 483 483 483 483 483 
IPTp-SP Correlation 
coefficient 
0.042 1.000 0.031 0.030 0.097* 
P-value 0.362      - 0.503 0.509 0.032 
N 483 483 483 483 483 
CAM use Correlation 
coefficient 
0.015 0.031 1.000 -0.054 0.008 
P-value 0.744 0.503 - 0.235 0.860 





-0.055 0.030 0.054 1.000 0.475** 
P-value 0.228 0.509 0.235 
 
- 0.000 
N 483 483 483 483 483 
ITNs use Correlation 
coefficient 
0.031 0.097* 0.008 0.475** 1.000 
P-value 0.491 0.032 0.860 0.000 - 
N 483 483 483 483 483 
Note: Perfect correlation denoted with plus/minus 0.70/0.80 
**Correlation is significant at the 0.01 level (P-value). 
*Correlation is significant at the 0.05 level (P-value)  
This table shows that the correlation among the binary independent/predictor variables 






The Result of the Correlation Analysis to Access the Correlation among the 
Categorical Independent Variables 
 
Note: Perfect correlation denoted with plus/minus 0.70/0.80 
**Correlation is significant at the 0.01 level (2-tailed). 
*Correlation is significant at the 0.05 level (2-tailed)  
This table shows the correlation among the categorical independent/predictor variables 




The Result of the Tolerance and VIF 
 
IVs Tolerance VIF 
Spearman’s 
Rho 
   Correlations 









1.000 0.175** 0.400** 0.051 
P-value     - 0.000 0.000 0.264 






0.175** 1.000 0.105* 0.061 
P-value 0.000    - 0.021 0.180 






0.105* 1.000 0.062 
P-value 0.000 0.021    - 0.173 






0.051 0.061 0.062 1.000 
P-value 0.264 0.180 0.173    - 
N 483 483 483 483 
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PMPM 0.991 1.009 
IPTp-SP compliance 0.988 1.012 
CAM use now 0.995 1.005 
ITNs ownership 0.766 1.305 
ITNs frequent usage 0.764 1.309 
 
The Primary Analysis Phase 
The Descriptive and the Analytic Statistics of the Findings 
 The descriptive statistics explains the details of the 
demographic/sociodemographic, placental malaria parasitemia/obstetrics, and the malaria 
intervention variables. I presented the details in Tables 5, 6, and 7, respectively. There 
were 483 research participants in the study with a response rate of 99.2%. The minimum 
and maximum age of the subjects that participated in this study were 18 years and 48 
years, respectively with a mean age of 28.09 years and standard deviation (SD) of 5.472. 
About twenty-six percent (25.9%) were between the ages of 18–25 years. Sixty percent 
of the subjects were between the ages of 26–34 years, 12.8% were between the ages of 
35–42 years, and 1.2% were between the ages of 43–49 years. Most (93.6%) of the 
subjects were married, and only 6.4% were unmarried. Less than two percent (1.9%) had 
no form of formal education, 2.1% had a primary education, 44.9% had a secondary 
education, and 51.1% had a tertiary education. Of all the subjects, 57.6% owned ITNs but 
only 26.3% reported sleeping under it frequently. While 44.3% obtained it from the 
ANC, 10.1% purchased it. Furthermore, 77.0% of the study population had attended the 
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ANC more than twice before delivery. The descriptive statistics on gravidae are 20.1% (n 
= 97), 34.4% (n = 166), and 45.5% (n = 220) for primigravidae, secundigravidae, and 
multigravida, respectively. The descriptive statistics on the use of CAM showed that 
17.6% of the subjects in this study use CAM during this pregnancy. Also, only 15.3% 
had three or more doses of the IPTp-SP. The mean value of hemoglobin (in g/dL) was 
11.02 and the SD value of hemoglobin (in g/dL) was 0.911. The univariate analysis of 




The Descriptive Statistics of the Demographic and Sociodemographic Variables of 
Subjects in this Study. 
 
Variable Frequency (N) Percentage (%) 
 Age group (years)   
18–25 125 25.9 
26–34 290 60.0 
35–42 62 12.8 
43–49 6 1.2 
Marital status  
Married 452 93.6 
Unmarried 31 6.4 
Educational attainment  
None 9 1.9 
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Primary 10 2.1 
Secondary 217 44.9 
Tertiary 247 51.1 
Employment status  
Unemployed 134 27.7 
Employed 349 72.3 
Mobile phone ownership  
No 23 4.8 
Yes 460 95.2 
Internet access  
No 176 36.4 
Yes 307 63.6 
Access to WhatsApp  
No 179 37.1 
Yes 304 62.9 
Access to Facebook  
No 188 38.9 




The Descriptive Statistics of the Placental Malaria Parasitemia and the Obstetrics 




Variable Frequency (N) Percentage (%) 
Maternal anemia   
 AA          282  58.4 
       AP          201  41.6 
Baby’s birth weight (kg)  
 NBW  421  87.2 
 LBW  62  12.8 
Delivery Term/Gestational Age at Delivery   
 TD  434  89.9 
 Preterm  49  10.1 
PMPRDT   
 NPMPRDT   454  94.0 
 PPMPRDT  29  6.0 
PMPM   
 NPMPM  218  45.1 
 PPMPM  265  54.9 
Gravidae  
        Primigravidae    97  20.1 
    Secundigravidae  166  34.4 






The Descriptive Statistics of the Malaria Intervention Variables in this Study. 
 
Variable Frequency (N) Percentage (%) 
IPTp-SP compliance 
Adequate 74 15.3 
Inadequate 409 84.7 
CAM  
No 398 82.4 
Yes 85 17.6 
ITN ownership  
No 205 47.4 
Yes 278 57.6 
ITN frequent use  
No 356 73.7 
Yes 127 26.3 
 
The result of the Chi-square analysis (bivariate analysis). 
 The results of the Chi-square analysis are itemized below and summarized in 
Table 8. 
1. The Chi-square analysis between PMPM and the ownership of ITN revealed that 
there is no statistically significant association between PMPM and the ownership 
of ITNs. 
χ 2  (1.458, df = 1, P = 0.227). 
2. The Chi-square analysis between PMPM and the usage of ITN on frequent bases 
revealed that there is no statistically significant association between PMPM and 
the usage of ITNs on frequent bases. 
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χ 2  (0.46, df = 1, P = 0.490) 
3. The Chi-square analysis between PMPM and ANC attendance revealed that the 
association tend towards significance. 
χ 2  (5.949, df = 2, P = 0.051).  
4. The Chi-square analysis between PMPM and gravidae revealed that there is no 
statistically significant association between PMPM and gravidae. 
χ 2  (3.848, df = 2, P = 0.146). 
5. The Chi-square analysis between PMPM and Age groups revealed that there is no 
statistically significant association between PMPM and Age groups. 
χ 2  (2.582, df = 3, P = 0.461 ). 
6. The Chi-square analysis between PMPM and educational attainment revealed that 
there is a statistically significant association between PMPM and educational 
attainment. 
χ 2  (12.852, df = 2, P = 0.020). 
Table 8. 
 
The Summary Results from the Chi-square Analysis. 
 
          PMPM 
IVs N  Pearson χ 2 df  P-value 
INTs Ownership 483  1.458a 1  0.227 
INTs Freq. Usage 483  0.476a 1  0.490 
ANC attendance 483  5.949a 2  0.051 
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Gravidae 483  3.848a 2  0.146 
Age groups 483  2.582 3  0.461 
Educational 
attainment 




The Prevalence of Placental Malaria, LBW, and Preterm Deliveries in the Study 
 The prevalence of placental malaria by microscopy and RDT in this study was 
54.9% and 6.0% respectively. The prevalence of PMPM was highest among the 
secundigravida (60.8%), followed by the primigravida (53.6%) and lowest among the 
multigravida (50.9%) in this study population. Maternal anemia was 41.6%, with 28.6% 
having mild anemia and 13.3% having moderate anemia; there were no cases of severe 
anemia in this study. LBW was 12.8%, and preterm delivery was 10.1%. Moreover, only 
P. falciparum specie were identified in this study. There were 49.9% of mild (+)  
parasitemia cases, while only 5.0% were moderate (+ +) by microscopy. The mild cases 
were also positive by the RDT. There was no severe (+ + +), and hyper (> + + +) 
parasitemia malaria cases in this study. The vast difference in prevalence between 
microscopy (49.9%) and RDT (6.0%) was attributed to the high false-negative by RDT 
testing techniques.  
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 The Prevalence of Placental Malaria, LBW, and Preterm Deliveries Across 
the Three Healthcare Facilities in this Study 
 The prevalence of placental malaria by microscopy in the primary, secondary, and 
private healthcare facilities were 44.3%,  33%, and 64.5%, respectively. The LBW across 
the primary, secondary, and private were 21.4%, 9.7%, and 11.9%. Preterm deliveries 
yielded a prevalence of 21.4%, 6.8%, and 8.7% across the three facility levels. Finally, 
60.0%, 63.1%, and 30.6% were anemic across the primary, secondary, and private 
healthcare facilities. These statistics are presented in Table 9 below. 
Table 9. 
 
The Prevalence of Placental Malaria, LBW, and Preterm Deliveries across the three  
Healthcare Facilities Levels in this Study. 
 
  Prevalence (%) 
Health facility level PMPM LBW Preterm Anemia 
Primary facility 44.3  21.4 21.4 60.0 
Secondary (Government) facility 33 9.7 6.8 63.1 
Private facility 64.5 11.9 8.7 30.6 
 
Logistic Regression Analysis in Relation to RQ1 
 The result of the logistic regression analysis to determine the association between 
PMPM (IV1), IPTp-SP compliance (IV2), the use of CAM (IV3), and maternal anemia 
(DV) among pregnant women in the study population showed a statistically significant 
effect on maternal anemia based on the P-value in the model indicated in Table 10; χ 2  
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(3) = 14.562, P = 0.002. The model explained 4.0% (Negelkerke’s R2) of the variances in 
maternal anemia and correctly classified 58.4% of cases. The performance of the PMPM 
was statistically significant (odd ratio of 0.584, CI: 0.403–0.847, P = 0.005). The 
subjects with PPMPM were 0.584 times as likely (58.4% more likely) to exhibit maternal 
anemia than the subjects with NPMPM. Also, the use of CAM (odd ratio = 1.631, CI: 
1.014–2.625, P = 0.044) was associated with an increase in the likelihood of exhibiting 
maternal anemia in this model. However, the IPTp-SP compliance variable was not 
statistically significant (odd ratio = 1.426, CI: 0.842–2.415, P = 0.186). The Hosmer-
Lemeshow test was not significant with a P-value of 0.640, implying that the model has a 
good fit. Subsequent on the above, I rejected the null hypotheses and accepted the 
alternate hypotheses in respect to RQ1. 
Table 10. 
 
The Omnibus Test of Model Coefficients for Research Question 1 Analysis. 
 
Step 1  Chi-square Df P-value 
Step 14.562 3 0.002 
Block 14.562 3 0.002 
Model 14.562 3 0.002 
Note: This table shows the statistical significance of the model explored in RQ 1. 
Table 11. 
 
The Variables in the Equation for Research Question 1 Analysis. 
 
   B S.E Wald Df P-value Exp(B) 
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The Result of the Logistic Regression Analysis for the Individual Performance of the 
Variables in the Equation for Research Question 1 Analysis. 
 
                            95% CI 
      Β S.E Wald Df P-value Odd ratio LCI UCI 
Step 1a PMPM -0.538 0.190 8.058 1 0.005 0.584 0.403 0.847 
IPTp-SP compliance 0.355 0.269 1.747 1 0.186 1.426 0.842 2.415 
CAM use 0.489 0.234 4.068 1 0.044 1.631 1.014 2.625 
Constant -0.493 0.266 3.431 1 0.064 0.611   
Variable (s) entered on step 1: PMPM, IPTp-SP compliance, CAM use. This table shows 
the statistical significance of each variable being explored in RQ1. 
Table 13. 
 
The Hosmer-Lemeshow Test for Research Question 1 Analysis. 
 
Step 1 Chi-square statistics Df P-value 
            2.528  4    0.640 
 
 
Logistic Regression Analysis in Relation to RQ2 
 The result of the logistic regression analysis of the association between PMPM 
(IV1), IPTp-SP compliance (IV2), the use of CAM (IV3), and baby’s birth weight (DV) 
among pregnant women in the study population showed a statistically significant effect 
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on baby’s birth weight based on the P-value in the model indicated in Table 14,  χ 2  (3) 
= 35.822, P = 0.000. The model explained 13.4% (Negelkerke’s R2) of the variances in 
baby’s birth weight and correctly classified 87.2% of cases. The performance of the 
PMPM was statistically significant (odd ratio = 0.171, CI: 0.082–0.357, P = 0.000), the 
subjects with PPMPM were 0.171 times as likely (17.1% more likely) to deliver LBW 
babies than the subjects with NPMPM. Also, the use of CAM (odd ratio = 2.212, CI: 
1.174–4.168, P =  0.014) was associated with an increase in the likelihood of delivering 
LBW babies in this model. However, the IPTp-SP compliance variable was not 
statistically significant (odd ratio = 1.139, CI: 0.504–2.578, P = 0.744). The Hosmer-
Lemeshow test was not significant with a P-value of 0.985, implying that the model has a 
good fit. Based on the stated result, I rejected the null hypotheses and accepted the 
alternate hypotheses in respect to RQ2. 
Table 14. 
 
The Omnibus Test of Model Coefficients for Research Question 2 Analysis. 
 
Step 1  Chi-square Df P-value 
Step 35.822 3 0.000 
Block 35.822 3 0.000 
Model 35.822 3 0.000 
Note: This table shows the statistical significance of the model explored in RQ 2. 
Table 15. 
 




B S.E Wald Df P-value Exp(B) 




The Result of the Logistic Regression Analysis for the Individual Performance of the 
Variables in the Equation for Research Question 2 Analysis. 
 
                          95% CI 





Step 1a PMPM -1.766 0.375 22.126 1 0.000 0.171 0.082 0.357 
IPTp-SP 
compliance 
0.130 0.417 0.098 1 0.754 1.139 0.504 2.578 
CAM use 0.794 0.323 6.036 1 0.014 2.212 1.174 4.166 
Constant -1.671 0.401 17.362 1 0.000 0.188   
 Variable (s) entered on step 1: PMPM, IPTp-SP compliance, CAM use. This table shows 
the statistical significance of each variable being explored in RQ2. 
Table 17. 
 
The Hosmer-Lemeshow Test for Research Question 2 Analysis. 
 
Step 1 Chi-square Df P-value 




Logistic Regression Analysis in Relation to RQ3 
 The result of the logistic regression analysis of the association between PMPM 
(IV1), IPTp-SP compliance (IV2), the use of CAM (IV3), and delivery term (DV) among 
pregnant women in the study population revealed a statistically significant effect on 
delivery term based on the P-value in the model indicated in Table 18; χ 2  (3) = 16.330, 
P = 0.001. The model explained 7.0% (Negelkerke’s R2) of the variances in the delivery 
term and correctly classified 89.9% of cases. The performance of the PMPM was 
statistically significant (odd ratio = 0.365, CI: 0.185–0.722, P = 0.004), the subjects with 
PPMPM were 0.364 times as likely  (36.4% more likely) to deliver preterm babies than 
the subjects with NPMPM. However, the IPTp-SP compliance and use of CAM variables 
were not statistically significant with the following details: odd ratio = 2.847, CI: 0.855–
9.481, P = 0.088; odd ratio = 1.782, CI: 0.890–3.568, P = 0.103 respectively. The 
Hosmer-Lemeshow test was not significant with a P-value of 0.666, implying that the 
model has a good fit. Therefore, I rejected the null hypotheses and accepted the alternate 
hypotheses in respect to RQ3. 
Table 18. 
 
The Omnibus Test of Model Coefficients for Research Question 3 Analysis. 
 
Step 1  Chi-square Df P-value 
Step 16.330 3 0.001 
Block 16.330 3 0.001 
Model 16.330 3 0.001 





The Variables in the Equation for Research Question 3 Analysis. 
 
 B S.E Wald Df P-value Exp(B) 




 The Result of the Logistic Regression Analysis for the Individual Performance of the 
Variables in the Equation for Research Question 3 Analysis. 
  
                       95% CI 
      Β S.E Wald Df P-
value 
Odd ratio LCI UCI 
Step 1a PMPM -1.008 0.348 8.400 1 0.004 0.365 0.185 0.722 
IPTp-SP 
compliance 
1.046 0.614 2.906 1 0.088 2.847 0.855 9.481 
CAM use 0.578 0.354 2.658 1 0.103 1.782 0.890 3.568 
Constant -2.884 0.606 22.628 1 0.000 0.056   
a. Variable (s) entered on step 1: PMPM, IPTp-SP compliance, CAM usage. This 
table shows the statistical significance of each variable being explored in RQ3. 
Table 21. 
 
The Hosmer-Lemeshow Test for Research Question 3 Analysis. 
 
Step 1 Chi-square Df P-value 




Controlling for Confounders in this Study Analysis 
The Result of Controlling for Confounders Relative to RQ1 in the Logistic 
Regression Model. 
 Finally, I used the backward elimination stepwise method in the SPSS to build the 
final model for this study based on the RQs. In building the final model based on the RQ1 
(maternal anemia as DV, the IVs were PMPM, IPTp-SP, and use of CAM) and the 
enumerated risk factors (ITN ownership, ITN frequent use, ANC attendance, gravidae, 
age groups, and educational attainment) were entered into the SPSS for logistic 
regression model with the backward elimination stepwise method. The output from the 
model showed that PMPM, use of CAM, ITN ownership, ITN frequent use, and ANC 
attendance showed statistically significant association with the outcome (maternal 
anemia), hence these variables were used with the DV (maternal anemia) to run the final 
model with the enter method of the binary logistic regression, χ 2 (5) = 74.922, P = 
0.000. This model explained 22.0% (Negelkerke’s R2) of the variances in the maternal 
anemia and correctly classified 78.5% of cases. The subjects with PPMPM were 0.135 
times as likely (13.5% more likely) to be anemic (exhibit maternal anemia) than the 
subjects with NPMPM. The performance of each variable is presented in Table 24 below. 
The Hosmer-Lemeshow test was not significant with a P-value of 0.818, implying that 
the model has a good fit. 
Table 22. 
 




Step 1  Chi-square Df P-value 
Step 74.922 5 0.000 
Block 74.922 5 0.000 
Model 74.922 5 0.000 
Note: This table shows the statistical significance of the model explored in RQ 1 final 
model. 
Table 23. 
   
The Variables in the Equation for Research Question 1 Final Model. 
 
 B S.E Wald Df P-value Exp(B) 




The Result for Controlling for Confounding for Research Question 1 Final Model. 
Analysis. 
 
                 95% CI 





Step 1a PMPM -2.002 0.298 45.086 1 0.000 0.135 0.075 0.242 
CAM use 0.654 0.292 5.019 1 0.025 1.923 1.085 3.408 





-0.752 0.309 5.940 1 0.015 0.471 0.257 0.863 
ANC 
attendance 
-0.400 0.193 4.314 1 0.038 0.670 0.460 0.978 
Constant 0.113 0.557 0.041 1 0.839 1.120   
a Variable (s) entered on step 1: PMPM, CAM usage, ITNs ownership, ITNs 
frequent use, and ANC attendance. This table shows the statistical significance of 
each variable being explored in RQ 1 final model. 
Table 25. 
 
The Hosmer-Lemeshow Test for Research Question 1 Final Model. 
 
Step 1 Chi-square Df P-value 
 4.413 8 0.818 
 
The result of controlling for confounders relative to RQ2 in the logistic regression 
model. 
 Also, in building the final model based on the RQ2 (baby’s birth weight as DV, 
IVs were PMPM, IPTp-SP, and use of CAM) and the enumerated risk factors (ITNs 
ownership, ITNs frequent use, ANC attendance,  gravidae, age groups, and educational 
attainment) were entered into the SPSS for logistic regression model with the backward 
elimination stepwise method. The output from the model showed that PMPM, use of 
CAM, and gravidae were statistically significantly associated with the outcome (baby’s 
birth weight), hence these variables were used with the DV (baby’s birth weight) to run 
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the final model with the enter method of the binary logistic regression. χ 2  (3), 41.297, P 
= 0.000. The model explained 15.3% (Negelkerke’s R2) of the variances in the baby’s 
birth weight and correctly classified 87.2% of cases. The subjects with PPMPM were 
0.174 times as likely (17.4% more likely) to deliver LBW babies than the subjects with 
NPMPM. The performance of each variable is presented in Table 28 below. The Hosmer- 
Lemeshow test was significant with a P-value of 0.013, implying that the model does not 
have a good fit. 
Table 26. 
 
The Omnibus Test of Model Coefficients for Research Question 2 Final Model Analysis. 
 
Step 1  Chi-square Df P-value 
Step 41.297 3 0.000 
Block 41.297 3 0.000 
Model 41.297 3 0.000 
Note: This table shows the statistical significance of the model explored in RQ 2 final 
model. 
Table 27. 
   
The Variables in the Equation for Research Question 2 Final Model Analysis. 
 
B S.E Wald Df P-value Exp(B) 








                     95% CI: 
     Β S.E Wald Df P-value Odd ratio LCI UCI 
PMPM -1.746 0.376 21.552 1 0.000 0.174 0.083 0.365 
CAM use 0.693 0.330 4.424 1 0.035 2.000 1.048 3.815 
Gravidae -0.434 0.184 5.575 1 0.018 0.648 0.452 0.929 
Constant -0.606 0.428 2.006 1 0.157 0.545   
a Variable (s) entered on step 1: PMPM, CAM use, and gravidae. This table shows 
the statistical significance of each variable being explored in RQ 2 final model. 
Table 29. 
 
The Hosmer-Lemeshow Test for Research Question 2 Final Model. 
 
Step 1 Chi-square Df P-value 
 16.049   6 0.013 
 
The result of controlling for confounders relative to RQ3 in the logistic regression 
model. 
 In creating the final model based on the RQ3 (delivery term as DV), the IVs were 
PMPM, IPTp-SP, and use of CAM) and the enumerated risk factors (ITNs ownership, 
ITNs frequent use, ANC attendance, gravidae, age groups, and educational attainment) 
were entered into the SPSS for logistic regression model with the backward elimination 
stepwise method. The result showed that PMPM, age groups, gravidae, ANC attendance, 
and  ITN frequent use hah a statistically significant association with the outcome 
(delivery term), hence these variables were used with the DV (delivery term) to run the 
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final model with the enter method of the binary logistic regression, χ 2 (5) = 36.966, P = 
0.000. The model explained 15.3% (Negelkerke’s R2) of the variances in the delivery 
term and correctly classified 90.1% of cases. The subjects with PPMPM were 0.378 times 
as likely (37.8% more likely) to deliver preterm babies than the subjects with NPMPM. 
The performance of each variable is presented in Table 32 below. The Hosmer-





The Omnibus Test of Model Coefficients for Research Question 3 Final Model Analysis. 
 
Step 1  Chi-square Df P-value 
Step 36.966 5 0.000 
Block 36.966 5 0.000 
Model 36.966 5 0.000 
Note: This table shows the statistical significance of the model explored in RQ 3 final 
model. 
Table 31. 
   
The Variables in the Equation for Research Question 3 Final Model. 
 
B S.E Wald Df P-value Exp(B) 








                     95% CI: 
     Β S.E Wald Df P-
value 
Odd ratio LCI UCI 
PMPM -0.973 0.357 7.417 1 0.006 0.378 0.188 0.761 
Age groups 0.559 0.253 4.862 1 0.027 1.748 1.064 2.873 
Gravidae -0.651 0.222 8.628 1 0.003 0.521 0.338 0.805 
ITN 
frequent use 
-0.884 0.437 4.096 1 0.043 0.413 0.176 0.972 
ANC 
attendance 
-0.774 0.222 12.161 1 0.000 0.461 0.299 0.713 
Constant 0.654 0.735 0.791 1 0.374 1.923   
a Variable (s) entered on step 1: PMPM, age groups, gravidae, ITNs frequent use, 
and ANC attendance. This table shows the statistical significance of each variable 
being explored in RQ3 final model. 
Table 33. 
 
The Hosmer-Lemeshow Test for Research Question 3 Final Model. 
 
Step 1 Chi-square Df P-value 




Summary and Transition 
 The results from the analysis of the combination of primary (Government) and 
secondary (Government and public) clinical data from four healthcare facilities in Asaba, 
Delta State, Nigeria were presented. Using the sample size n = 483 and critical level of 
significance, P ≤ 0.05; Chi-Square and binomial logistic regression were the two 
statistical tests used to derive the results.  
 The RQ1 investigated whether there is an association between PMPM, IPTp-SP 
compliance, the use of CAM, and maternal anemia among pregnant women in Asaba, 
Delta State, Nigeria. The result showed that subjects with PPMPM were 58.4% more 
likely to exhibit maternal anemia than the subjects with NPMPM. The data also showed 
that the use of CAM was associated with an increase in the likelihood of exhibiting 
maternal anemia in the study population.  
 The RQ2 investigated whether there is an association between PMPM, IPTp-SP 
compliance, the use of CAM, and baby’s birth weight among pregnant women in Asaba, 
Delta State, Nigeria. The result showed that subjects with PPMPM were 17.1% more 
likely to deliver LBW babies than the subjects with NPMPM. And the use of CAM by 
parturients was associated with an increase in the likelihood of delivering LBW babies in 
the study population. 
 The RQ3 investigated whether there is an association between PMPM, IPTp-SP 
compliance, the use of CAM, and delivery term among pregnant women in Asaba, Delta 
State, Nigeria. The study findings showed that subjects with PPMPM were 36.4% more 
likely to deliver preterm babies than the subjects with NPMPM. 
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 Also, the identified risk factors associated with maternal anemia were ITN 
ownership, ITN frequent use, and ANC attendance, while the only risk factors associated 
with baby’s birth weight was gravidae. Besides, age groups, gravidae, ITN frequent use 
and ANC attendance were the risk factors associated with delivery term. 
 In this chapter, I discuss the data collection and preparation processes and I 
explain the representativeness of the sample to the population. I also discussed the use of 
the binomial logistic regression statistical tests that was performed and the reason for the 
use in this study. I reported the results from the analytical tests performed in line with the 
research questions and their hypotheses. In the next and final chapter, the interpretation 
of the results was discussed. The limitations of this study, recommendations for policy 
and program as well as gaps for future study, and positive social change implications 
were also discussed. 
Chapter 5: Discussion, Conclusion, and Recommendation 
Introduction 
 Malaria is a longstanding public health problem of global significance, and many 
efforts have been made to eliminate and eradicate the disease. Most malaria-endemic 
regions of the world, especially in the SSA and Nigeria, are among the low-income 
countries. The malaria control programs have not yielded the expected outcome, being 
compounded by poverty and low human resources (CDC, 2020; Onyemaechi & Malann, 
2020; WHO, 2020). About 47 of 54 countries in the SSA are malaria endemic and are 
still in the malaria control programs with persistent low statistics of intervention 
implementations (WHO, 2020). Malaria infection is a critical public health problem in 
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Nigeria and the SSA in general despite the available interventions such as the IPTp-SP, 
ITNs, and treatment regime to prevent P. falciparum infection in pregnancy (Yaya et al., 
2018; Braun et al., 2015). An estimated 25–30 million of the 125,000,000 parturients at 
risk of malaria globally are in the SSA. There is evidence in current documents of an 
estimated 75,000 to 200,000 neonatal mortalities, 900,000 LBW babies, and 10,000 
maternal mortalities in the SSA region annually due to malaria disease (CDC, 2020; 
Onyemaechi & Malann, 2020; WHO, 2020). As a result, several studies have been 
conducted to determine the risk factors accounting for the high prevalence of malaria 
morbidity and mortality among parturients and their infants in various regions.  
 The purpose of this cross-sectional study design with a quantitative methodology 
was to investigate the association between asymptomatic malaria infection and pregnancy 
outcome among pregnant women in Asaba, Delta State, Nigeria. I addressed a research 
gap concerning the variability of malaria risk factors as well as the existence of few 
evidence of MiP among parturients and pregnancy outcome, in Asaba, Delta State, 
Nigeria. My specific objective was to ascertain disease prevalence, the prevailing risk 
factors for this location, the compliance levels of intervention use, and the intervention 
that gives successful outcome in the study area. The evidence in current documents have 
not determined the association between PMPM and pregnancy outcome in the study 
location. The current evidence of similar studies in various locations revealed that the risk 
factors are location specific (Aguzie, 2018). The compliance and success of existing 
intervention have regional/location specificity (CDC, 2020; WHO, 2020). 
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 I used a combination of primary (survey questionnaires) and secondary (routine 
healthcare facility) data to answer the three RQs for this study. In this chapter, I 
interpreted the findings, discuss the limitations of the study, made recommendations for 
future research, suggested implications for social change, and summation. 
Interpretation of Findings 
 The findings of this cross-sectional study design using a quantitative research 
methodology aligned with most of the previous studies conducted on MiP. However, 
some results differed.  
  The RQ1 was used to investigate whether there is an association between PMPM, 
IPTp-SP compliance, the use of CAM, and maternal anemia among pregnant women in 
Asaba, Delta State, Nigeria. The result of the analysis of RQ1 indicated that PMPM, 
IPTp-SP compliance, and CAM have statistically significant association with maternal 
anemia at delivery based on the P-value in the model as shown in Table 10. The result of 
the analysis of RQ1 indicated that subjects with PPMPM were 58.4% more likely to 
exhibit maternal anemia than the subjects with NPMPM. The data also showed that the 
use of CAM was associated with an increase in the likelihood of exhibiting maternal 
anemia in the study population. 
  I used the RQ2 to investigate whether there is an association between PMPM, 
IPTp-SP compliance, the use of CAM, and baby’s birth weight among pregnant women 
in Asaba, Delta State, Nigeria. The PMPM, IPTp-SP compliance, CAM use were 
statistically significantly associated with baby’s birth weight based on the P-value of the 
model as shown in Table 14. The data showed that subjects with PPMPM were 17.1% 
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more likely to deliver LBW babies than the subjects with NPMPM. And the use of CAM 
by parturients was associated with an increase in the likelihood of delivering LBW babies 
in the study population. 
 I used the RQ3 to investigate whether there is an association between PMPM, 
IPTp-SP compliance, the use of CAM, and delivery term among pregnant women in 
Asaba, Delta State, Nigeria. The result showed a statistically significant association 
between PMPM, IPTp-SP compliance, CAM, and delivery term in this study as observed 
in the analysis of the RQ3 based on the P-value in the model indicated in Table 18. The 
result demonstrated that subjects with PPMPM were 36.4% more likely to deliver 
preterm babies than the subjects with NPMPM. 
 The expanded models involving the risk factors of malaria revealed that maternal 
anemia has a statistically significant association with PMPM, use of CAM, ITN 
ownership, ITN frequent use, and ANC attendance. The identified risk factors associated 
with maternal anemia were ITN ownership, ITN frequent use, and ANC attendance. The 
baby’s birth weight showed a statistically significant association with PMPM, CAM use 
and gravidae. The only risk factors associated with baby’s birth weight was gravidae. 
While the delivery term demonstrated a statistically significant association with PMPM, 
age groups, gravidae, ITN frequent use and ANC attendance. Therefore, age groups, 




Malaria Prevalence Among the Study Population 
 The confirmation and identification of the parasite by the thick and thin slide 
microscopy showed 100% of P. falciparum in the data. Buh et al. (2019) and Ouedraogo 
et al. (2012) reported similar results in their various studies. The result of this study is 
aligned with a study conducted by Omer et al. (2021) and several other studies carried out 
in the SSA regions (Lufelu et al., 2017; Omer et al., 2017; Onyemaechi & Malann, 2020). 
This agrees with the documented evidence that 25 million parturients are at risk of 
malaria infection by P. falciparum in the SSA (Balami et al., 2021; WHO, 2020, CDC, 
2020). Furthermore, this agrees with the study by Omer et al. (2017) in Uganda, who also 
reported the identification of only P. falciparum. Besides, Anorue et al. (2020) and Achu 
et al. (2020) in their studies in Asaba also reported only P. falciparum species. 
Prevalence Across the Healthcare Facility Levels  
 The prevalence of placental malaria by microscopy in the primary, secondary, and 
private healthcare facilities were 44.3%, 33.0%, and 64.5%, respectively. The prevalence 
of LBW across the primary, secondary, and private facilities were 21.4%, 9.7%, and 
11.9%. Preterm deliveries yielded a prevalence of 21.4%, 6.8%, and 8.7% across the 
three facility levels. Finally, 60.0%, 63.1%, and 31.0% were the observed prevalence for 
anemia across the primary, secondary, and private healthcare facilities. 
Prevalence of Major Variables in this Study 
 The prevalence of placental malaria by microscopy and RDT in this study were 
54.9% and 6.0% respectively. The wide difference in prevalence between microscopy 
and RTD malaria testing techniques in this study was due to the observed large false 
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negative result by the RDT. The prevalence of placental malaria was highest among the 
secundigravida (61.0%), followed by the primigravida (54.0%) and lowest among the 
multigravida (51.0%) in the study population. Maternal anemia was 41.6%, LBW was 
12.8%, and preterm delivery was 10.1%. The result of the PMPM showed that only P. 
falciparum specie were identified in this study. In addition, the prevalence of the use of 
CAM in this study was 17.6%, IPTp-SP adequate compliance was 15.3%. While the 
prevalence of the ITN ownership and ITN frequent use were 57.6% and 26.3%, 
respectively.  
 The result of 54.9% prevalence of placental malaria parasitemia by microscopy in 
this study lend its support to the concept of asymptomatic malaria infections and its 
impact on maternal and neonatal health (Omer et al., 2017; Onyemaechi & Malann, 2020; 
Odorizzi et al., 2016). Malaria parasite asymptomatic state in a high burden malaria area 
have implication in maintaining the parasite circle and delaying the malaria elimination 
and eradication program (Berzosa et al., 2018; Katrack, et al., 2018). Although malaria 
infection in the SSA (a high burden malaria region) is mostly asymptomatic due to the 
acquired immunity via repeated exposures, it is still highly associated with maternal 
anemia, still birth, LBW babies, preterm deliveries, maternal and neonatal complications, 
and death (Aguzie, 2018; Balami et al. 2021; Bardaji et al., 2017; Omer et al., 2017). The 
observed high prevalence of mild (+) parasitemia in this study aligns with the report by 
Quakyi et al. (2019) that low density parasitemia is common in high burden malaria 
regions. The high prevalence of placental malaria parasitemia in this study could be 
explained by the report by Kapisi et al. (2017) that high burden malaria relates to 
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placental malaria parasitemia. Furthermore, Anorue et al. (2020) reported a higher 
prevalence (65.8%) by microscopy from their study in a tertiary healthcare facility in 
Asaba, Delta State, Nigeria, while Omer et al. (2017) reported 58.9% of placental malaria 
by microscopy in Uganda. 
Maternal Anemia Among the Study Population 
 The prevalence of maternal anemia in this study was 41.6%. Rouamba et al. 
(2021) reported similar prevalence of anemia (35.9% and 46.6%) with data collected in 
2013/2014 and 2017 in Burkina Faso. Although Olukosi and Afolabi (2018) in their study 
in Lagos, Nigeria had higher results of 81.4% prevalence of anemia. According to Desai 
et al. (2007), malaria infection is highly associated with anemia and poor pregnancy 
outcome at all levels of pregnancy, while White, (2018) reiterated that malaria infection 
is associated with maternal anemia. These authors stated that P. falciparum is directly 
linked with maternal death in a low transmission setting while in a high transmission 
setting, it is an indirect cause of mortality via maternal anemia. The present study also 
revealed a strong association between placental malaria, maternal anemia, preterm 
deliveries, and LBW. Omer et al. (2021) reported that placental malaria impacted the 
immune response that may change the hemoglobin level of the parturients and the 
neonates birth weight. Therefore, a successful pregnancy outcome is dependent on the 
placental. The analysis of the data in this study showed a strong association between 
maternal anemia and placental malaria. The prevalence of maternal anemia in this study 
is higher among subjects with PPMP than in the subjects with NPMP as shown in the 
results outlined in Chapter 4. There is a statistically significant association between 
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malaria infection and maternal anemia in pregnancy by various authors across different 
locations in the SSA (Olukosi & Afolabi, 2018; Rouamba et al. 2021; White, 2018). 
Nevertheless, several studies reiterated that the cause of anemia is multifactorial 
(Rouamba et al., 2021; Renzo et al., 2015; Tabrizi & Barjasteh, 2015); worm infestation, 
nutritional deficiency, poverty, low SES, and poor nutrition have been widely reported in 
connection with anemia (Ononga et al., 2014; Haider et al., 2013). 
 The reported prevalence of 17.6% of the use of CAM aligns with the report by 
Ogbonnaya et al. (2019) that there is widespread belief among parturients in Nigeria that 
the use of CAM is safe. Nergard et al. (2015) also reported on the increasing use of CAM 
by parturients in Mali and other African countries. 
 The low IPTp-SP compliance has been reported in the SSA (Amoakoh-Coleman 
et al., 2020; Roman et al., 2019). The use of ITN on frequent bases was below the 
expected standard (Aniekwe et al., 2020; Ezire et al., 2015). 
The Credibility of the Testing Techniques (RDT and Microscopy) 
 Contrary to the outcome of the study by Mfuh et al. (2019), who reported that the 
RDTs was more sensitive than microscopy, the reverse was the finding in this study. 
These authors stated that age-specific detection of the Plasmodium species was like that 
of the PCR tests. However, they reported a high false positive result by RDTs compared 
to microscopy and they reiterated that a positive malaria parasite by microscopy is 
trustworthy; nevertheless, a negative result does not exclude the presence of the parasite 
(Mfuh et al., 2019). This implies that the prevalence reported in this study may not be 
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less but rather higher with the PCR testing techniques, except for the possible minor 
impact of the limitations of the microscopists with respect to expertise.  
 Berzosa et al. (2018) concluded that the RDTs are limited, and that microscopy 
should be used for prevalence studies. This gives credence to the use of microscopy for 
the confirmation of the malaria parasitemia and specie identification in this study. 
Zakama et al. (2020) stated that RDTs are effective in diagnosing malaria in non-
pregnant subjects. These authors reiterated that RDTs are less efficient in diagnosing 
placental malaria  (Briggs et al., 2019). Vasquez et al. (2018) reported that a newer 
version of the RDT (HS–RDT) has higher sensitivity in testing placental parasitemia than 
the routine RDTs (HRP–2) currently available, which were used in this study. Metoh et 
al. (2020) concluded from their comparative study between RDTs and microscopy test 
for malaria parasite that microscopy showed a superior sensitivity compared to RDT 
methods of malaria diagnosis. These authors stated that microscopy is more reliable than 
RDTs in detecting malaria parasitemia in a high burden malaria area and further 
recommended the use of the alternatives to the PFHRP2RDTs for placental malaria 
diagnosis because the HRP2RDT series perform poorly in detecting placental malaria 
parasitemia. This could explain the poor performance of the RDT in this study. Berzosa 
et al. (2018) stated that the sensitivity of the RDTs is affected by low parasite densities 
and that between 100 parasite/µl, the RDTs performance is decreased. This is in line with 
the observation in this study, there are 49.9% of mild (+)  parasitemia cases by 
microscopy, and all the moderate (+ +)  (5%) in this study were positive by the RDT, 
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However, there was no severe (+ + +), and hyper parasitemia (> + + +) malaria cases in 
this study.  
Placental Malaria Parasitemia and IPTp-SP Compliance  
 I observed that there was no statistically significant association between 
compliance to IPTp-SP and placental malaria infection in this study. This could be 
explained by the fact that the compliance level observed in this study was below the 
current recommendation of four or more doses before delivery starting from the 4th month 
of pregnancy. Only 2.6% purchased the IPTp-SP that they used; others depended on its 
availability in the healthcare facility which was low across the three healthcare facility 
levels.  
The Study Result in Relation to the Socioecological Model Framework 
 The SEM describes the relationship between the individual, interpersonal (family, 
friends, and community), and system/structural levels. The SEM is valuable for the 
review, design, implementation, and evaluation of a comprehensive malaria control 
program. The factors influencing malaria control are multifactorial and the SEM is a 
good match for designing a sustainable malaria program. At the individual level, the 
parturients should use the existing malaria interventions to reduce their exposure and 
impact of the disease to them and their neonates. So, the sensitization of parturients to 
utilize the existing malaria interventions to reduce the prevalence of the disease should be 
encouraged. At the interpersonal level (household, family, and community) involves the 
influences of the social support system. Training focused on the interpersonal 
connections of parturients to reduce their vulnerability to malaria infection will enhance a 
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positive pregnancy outcome. Appropriate information to family, friends and community 
members could scale up the use of malaria interventions by parturients. In fact, malaria 
elimination and eradication require community mobilization and involvement. And 
finally at the system level of the SEM, policies and programs on malaria control should 
focus on the various supports and connections of parturients to enhance pregnancy 
outcome. The use of the SEM in this study has highlighted the importance of the multiple 
levels of engagement to enhance maternal and neonatal improved pregnancy outcome.  
Limitation of the Study 
 The limitation of the study is the absence of a molecular testing/analysis (via the 
PCR or histology) of the placental parasitemia of the malaria parasite, which is 
attributable to financial constrain. These techniques have improved sensitivity, 
specificity, and can quantify parasitemia (with respect to the PCR) (Mfuh et al., 2019). In 
addition, the use of hospital routine data of placental malaria by RDTs and microscopy, 
implies that misdiagnosis cannot be ruled out with respect to errors in reading by the 
microscopist, accurate staining of slides, or misidentification of the parasite species. 
Therefore, I was not in control of the quality of these secondary data. Furthermore, the 
survey questionnaires were based on self-reporting, hence, re-call and information bias 
could not be ruled out and the quality of the collected data may not be in the 
desired/required standard. In addition, I observed about 2.6% of missing and incomplete 
data and after all efforts to complete them were explored without success, they were 
removed from the data used in the final analysis and this could impact the internal 
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validity of the study. Also, the result of this study was limited to the Asaba city in Delta 
State, Nigeria. Hence, it cannot be generalized to Delta State or Nigeria. 
Recommendations 
 This study resulted in some interesting findings that can contribute to the current 
body of knowledge in MiP research. There is need for further study using the PCR or 
histology techniques which has a lower limit of detection of the P. falciparum of about 
0.0001 parasite/µl as well as detecting mixed infections but microscopy cannot detect 
mixed infection (Berzosa, et al., 2018). Besides, the result of the RDT analysis in this 
study calls for further investigation because the RDTs are meant to detect the antigens of 
plasmodium species and not the parasites; implying it should have a sensitivity advantage 
over the thick film microscopy because it should (by design) pick parasitemia below the 
threshold of microscopy (Mfuh, et al., 2018). Therefore, an enhanced/improved testing 
techniques is required to ascertain the false negative (due to threshold limit) by 
microscopy.  
 An adequate sensitization of parturients on the need to take the recommended 
doses of the IPTp-SP is urgently required. Further, policy could be reviewed at the local, 
state, and national government levels to focus on tracking and treating asymptomatic 
malaria cases via the inclusion of routine malaria testing for parturients during the ANC 
in the study location. I also recommend that further studies should be carried out to 
determine the components/active ingredients of the CAM used by pregnant women 
against malaria in the study location. And a cohort study on the comparism of the long-
time impact of IPTp-SP and CAM on pregnancy outcome is recommended. 
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Implication for Positive Social Change 
 The result of this study has provided information on the prevalence of placental 
malaria infection in Asaba, Delta State, Nigeria, which is necessary to guide institutions 
and stakeholders in malaria control programs. The healthcare facilities that provided the 
data should be sensitized on the study's outcome for enhanced care of the parturients 
subsequently. The statistics from this study on the utilization of existing malaria 
interventions are far below the expected target for elimination and eradication of this 
aged-long infection. There is need for a renewed and concerted efforts on parturients via 
the identified multiple levels of influences highlighted in the SEM (individuals, 
interpersonal, community, and system levels) on the need to use the ITNs, IPTp-SP, 
laboratory testing, and prompt treatment of malaria cases. The health education message 
should be clear that parturients are not sick of malaria does not exclude the fact that they 
could be carriers of the parasite, and their babies could be impacted. Besides, parturients 
may become sick subsequently via recrudesce. 
           The results of this study could affect positive social change at the individual, 
interpersonal, community, and system levels of the SEM. The study results showed that 
asymptomatic parturients have a high prevalence of malaria infection. The use of the ITN 
and IPTp-SP malaria interventions by subjects in this study were far below the expected 
threshold. Therefore, strategies such as health education at the ANC, community levels 
and disseminating this study results to the Delta State Ministry of Health and other 
malaria control stakeholders could enhance the use of the ITNs and IPTp-SP by 
parturients in this location and beyond.  Further, the findings from this study could have a 
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social change impact via the communication of study findings at the ANC study sites 
(result dissemination to subjects and stakeholders) and community town hall meeting 
could enhance social support from family and community members for parturients 
protection against mosquito bites and enhance the use of the existing interventions for the 
disease control.  
           Moreover, on the individual level, the communication of the findings of this study 
at the ANC, prenatal clinics, and social media blogs/professional website could lead to 
social change via the increase in the adoption of malaria interventions by parturients. This 
could reduce the morbidity and mortality due to MiP, yield improved pregnancy 
outcomes, and improved economic resources available to parturients in the study location 
and beyond. Further, policy on malaria elimination and eradication could be expanded at 
the local, state and, national government levels to focus on tracking and treating 
asymptomatic malaria cases among parturients via the inclusion of routine malaria testing 
for parturients during the ANC. So, expanding the current malaria control strategy of 
testing and treating only sick subjects to accommodate asymptomatic parturients in the 
testing and subsequent treatments when needed could reduce the present burden of MiP 
in this location. Also, strengthening the use of the ITN and IPTp-SP among subjects via 
adequate dissemination of this study findings could reduce MiP and yield improved 
pregnancy outcomes in this location. In addition, health education discouraging the use of 





 The high prevalence of placental malaria in this study could be attributed to the 
low utilization of the existing interventions (ITNs, IPTp-SP compliance) and it resulted in 
adverse pregnancy outcome (maternal anemia, LBW, and preterm deliveries) as reported 
in the result section. In this chapter, an overview of the research study, along with 
interpretations of the results of data analyses in view of the stated hypotheses, the 
alignment between the findings of the current study and previous research results 
reported in current literature are provided. In addition, public health recommendations 
were made based on the findings of the current study along with suggestions for future 
research as pertains to the statement of the problem that was addressed in this study.   
Incorporating the findings of this study to the existing body of evidence could guide the 
malaria control stakeholders to expand interventions to track and treat asymptomatic 
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Appendix A: The Questionnaire 
 Introduction: Good Morning/Afternoon/Evening Madam, my name is Sally Obi. I 
am a researcher and doctoral student from Walden University. I am here to invite you to 
answer some questions on a study on prevention of malaria among pregnant women. You 
might recall that the nurse gave you a consent form in the past. You have a choice of 
whether you would like to answer these questions or not. Your responses will only be 
used for research purposes and is aimed at supporting the health of women in Delta state 
and Nigeria. I assure you that all your responses will be treated as confidential and will 
not be discussed with any other person. This interview would last for about 15 minutes. 
Your participation is voluntary, and you can decide to stop the interview at any time if 
you do not want to continue. Would you like to volunteer to answer the questions for the 
study? Yes/No.  
Subject’s code/ID number: 
Section A: pregnancy outcome variables from laboratory and delivery units of 
healthcare. 
Question Response 




2. Record PMP by microscopy 
from the Laboratory. 
PPMP (1) 
NPMP(0) 
3. What is plasmodium specie 
present 
Write it here………………………….. 
4.What is the maternal anemia 
status? 
Just write down the value from the laboratory 
result……………………… It will be coded as: 
AA (0) 
AP (1)  
5.What is the maternal delivery 
term? 
Write down the value from the hospital file……..  
It will be coded as: Preterm (≤36 weeks) (0) 
Term (≥37 weeks) (1) 
6.What is the baby’s weight Write down the value from the hospital file ……  
It will be coded as: 
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 NBW (2.5kg and above) (0) 
LBW (< 2.5kg) (1) 
7. What is the maternal outcome Alive = 1 
Dead = 0 
8. What is the neonatal outcome Alive = 1 
Dead = 0 
 
   Section B: Demographic variables 
1. what is the month and year of 
your birth? 
Write it down……………………… 
2. How old were you in your last 
birthday? 
Write it down…………………….. 
3. How old are you now? 18-25 years  (1)  
26–34 years  (2) 
35–42 years  (3)  
43-49 years  (4)  
4. Are you married to the man you 
are living with now? 
Yes (1) 
No (0) 
5. What is your marital status Married (5), Widowed  (4),  
Separated (3), Divorced (2) 
Never married (1), Others specify……..  
6. Name the area you live? Interbau to Okpanam road (1) 
Ime-ogbe (2) 
 Bonsac (3)  
Oduke (4)  
Jarret/Cable (5) 
Infant Jesus Area (6) 
Behind Specialist Hospital (7) 
Across Koko (8) 
Across Submit (9) 
DLA (10) 
Others Specify (11) 
7. Have you ever attended school? Yes (1) 
No (0) 
8. What is your highest level of 
educational qualification? 
No formal Education (1)  
Primary Education (2)  
Secondary Education (3)  
Tertiary education (4) 
9. Are you currently employed? (self-employment or paid employment with 
income)  
Yes (1)  
No (0) 








12. How often do you access the 
internet with your phone? 
Daily (4) 
Weekly (3)  
Monthly (1) 
None (0) 




14. Do you have Facebook in your 
phone? 
Yes (1) 
No  (0) 
15. What materials are used for the 
roof of the house where you live? 
Thatched/ Palm leave (1) 
Wood/plank/Tarpaulin/Plastics (2)  
Zinc/Metal/Ceramic Tiles/Asbestos Sheet (3)  
Other (Specify)…………………….. 0 
16. Do you have mosquito net 




17. What is your ethnic group? Ibo, Urhobo, Itsekiri, Isoko, Ijaw, Hausa, 
Yoruba, Others…………………………………. 
(Tick the one that applies) 
18. How many children do you 




More than two (3) 
19. How many of your children are 




More than two (3) 
20. Do you have children that are 
not staying with you? 
Yes (1) 
No (0) 
21. How many of your children are 




More than two (3) 
22. How many times have you 
been pregnant?  
Once (1)   
Twice (2) 
More than two (3) 
23. How many ANC did you attend 




More than two (3) 




1. Have you taken IPTp-SP during 
this pregnancy? (Show the sample 
of a dose of SP)  
Yes (2) 
 No (0)  
Not sure(1)  
 
2. How many doses IPTp-SP doses 





More than two(3) 
3. Where did you get the IPTp-SP 
that you took during this 
pregnancy? 
None (0) 
ANC clinic (1) 
Purchased(2) 
4. Do you have insecticide treated 
net (ITN) against mosquito for 
your own use? 
Yes (1) 
 No (0)  
 
5. Where did you get the net? ANC (1) 
Purchased (0) 
6. Did you sleep under a treated 
mosquito net (ITN) last night?  
Yes (1)  
No (0) 
7. Do you sleep under a treated 
mosquito net (ITN) all the time? 
Yes (1) 
No (0) 
   Section D: other variables. 





9. How often do you take 




More than twice (3) 
10. Did you take 
herbal/plant/native medicine during 
this pregnancy for malaria? 
Yes (1) 
 No (0) 
Thank you for your responses to the survey questions. Can I use your responses for my 
research study as stated in the consent form, Yes  /  No. 
Definition of terms:  
PMP: Placental malaria parasitemia. 
RDT: Rapid diagnostic test. 
PPMP: Positive Placental malaria parasitemia. 
NPMP: Negative Placental malaria parasitemia. 
AA: Anemia absent. 
AP: Anemia present. 
NBW: Normal birth weight. 
LBW: Low birth weight. 
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